Inflammatory disease
MONDO:0021166A disease involving a pathogenic inflammatory response in the anatomical structure.
Also known as: anatomical structure inflammation, inflammation of anatomical structure, inflammatory disease, inflammatory disorder
10161 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 1606 trials in this tab.
-
Can engineered immune cells tackle a tough kidney disease?
⭐️ CURE ⭐️ Not yet recruitingThis trial is testing an experimental therapy called FKC289 for people with a type of kidney disease called primary membranous nephropathy that has come back or not responded to standard treatment. FKC289 uses the patient's own immune cells, which are modified in the lab to recog…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Fosun Kairos Biotechnology Co., Ltd. • Aim: ⭐️ CURE ⭐️
Last updated Aug 16, 2026 00:00 UTC
-
Can engineered immune cells stop a rare muscle disease?
⭐️ CURE ⭐️ Not yet recruitingThis early-stage trial is testing whether a personalized cell therapy called Eque-cel can safely and effectively treat people with refractory immune-mediated necrotizing myopathy (IMNM), a severe autoimmune condition that causes muscle weakness and damage. The therapy involves re…
Phase: PHASE1, PHASE2 • Sponsor: Nanjing IASO Biotechnology Co., Ltd. • Aim: ⭐️ CURE ⭐️
Last updated Aug 09, 2026 00:00 UTC
-
Can a single infusion of reprogrammed immune cells quiet lupus kidney disease?
⭐️ CURE ⭐️ Not yet recruitingThis phase 2 trial is testing whether a single infusion of a patient's own genetically modified immune cells, called C-CAR168, can safely and effectively treat lupus nephritis that has not responded to standard therapies. The cells are designed to target and eliminate specific im…
Phase: PHASE2 • Sponsor: AbelZeta Inc. • Aim: ⭐️ CURE ⭐️
Last updated Jul 30, 2026 00:00 UTC
-
Could a vaccine clear up severe teen acne?
⭐️ VACCINE ⭐️ Not yet recruitingThis trial is testing whether an experimental mRNA vaccine can safely reduce moderate-to-severe acne in adolescents aged 12 to 17. Participants receive either the vaccine at different dose levels or a placebo, and researchers monitor safety and changes in facial acne lesions. The…
Phase: PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 13, 2026 00:00 UTC
-
Next-Generation polio vaccine enters human testing
⭐️ VACCINE ⭐️ Not yet recruitingThis trial tests a new recombinant polio vaccine (rPV) against the current standard IPOL vaccine in healthy adults aged 18 to 60. The goal is to see if the new vaccine is safe and triggers a strong immune response. It is a small, early-stage study to gather initial data.
Phase: PHASE1 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 12, 2026 00:00 UTC
-
New vaccine aims to stop deadly diarrhea in kids
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine (IP-QSV) designed to protect against four types of Shigella bacteria, which cause severe diarrhea. The trial will include 370 healthy adults, children, and infants in Mali. Researchers will check if the vaccine is safe and triggers a strong immune r…
Phase: PHASE1, PHASE2 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:02 UTC
-
Can a new injection calm severe eczema in kids?
Disease control Not yet recruitingThis trial is testing an experimental drug called 611 in children aged 2 to 12 with moderate-to-severe atopic dermatitis, a common skin condition that causes itchy, inflamed skin. The drug is designed to block a specific immune signal that drives the inflammation behind eczema. T…
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a new pill silence stubborn hives?
Disease control Not yet recruitingThis trial is testing an experimental oral medication called THB335 in adults with chronic spontaneous urticaria (CSU), a condition marked by persistent hives and itching that standard antihistamines don't fully control. Participants will take THB335 or a placebo alongside their …
Phase: PHASE2 • Sponsor: Calixis Inc. • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a targeted biologic outperform standard care for a rare blistering disease?
Disease control Not yet recruitingThis trial compares two treatment approaches for moderate to severe pemphigus vulgaris, a rare autoimmune disease causing painful blisters on skin and mucous membranes. One group receives rituximab (a biologic that targets immune B-cells) plus corticosteroids, while the other get…
Phase: EARLY_PHASE1 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a flash of light beat a blinding eye infection?
Disease control Not yet recruitingThis study tests whether a light-activated treatment called Rose Bengal photodynamic therapy can help people with a severe fungal eye infection called Fusarium keratitis. The infection can cause vision loss, and standard treatments may not always work. Participants receive either…
Phase: PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a new injection plus a pill tame ulcerative colitis?
Disease control Not yet recruitingThis early trial is testing whether a new investigational drug called HX15001, given as an injection, can be safely combined with an existing pill (etrasimod) to treat moderate-to-severe ulcerative colitis. The study will include about 32 adults with the condition and will focus …
Phase: PHASE1 • Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can ancient ayurvedic remedies outperform modern medicine for knee pain?
Disease control Not yet recruitingThis trial tests whether combining traditional Ayurvedic treatments with standard medical care can better ease knee osteoarthritis symptoms than either approach alone. It enrolls 300 adults aged 30-65 with mild to moderate knee osteoarthritis, randomly assigning them to receive s…
Phase: NA • Sponsor: All India Institute of Medical Sciences, Jodhpur • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a new pill tame ulcerative colitis Flare-Ups?
Disease control Not yet recruitingThis clinical trial is testing an experimental oral medication called AC-101 in adults with moderately to severely active ulcerative colitis (UC), a chronic inflammatory bowel disease. The study aims to see if AC-101 can help achieve clinical remission—meaning fewer symptoms and …
Phase: PHASE2 • Sponsor: Accro Bioscience (Suzhou) Limited • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a targeted antibody boost kidney remission in lupus?
Disease control Not yet recruitingThis phase 3 trial is testing whether adding the drug obinutuzumab to the standard treatment (mycophenolate mofetil and corticosteroids) can improve outcomes for people with active lupus nephritis, a serious kidney complication of lupus. The study will enroll 70 adults aged 18-65…
Phase: PHASE3 • Sponsor: Zhao Minghui • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Root canal alternative? new procedure aims to save infected teeth
Disease control Not yet recruitingThis study tests whether a procedure called full pulpotomy can successfully treat permanent teeth with irreversible pulpitis and apical periodontitis. Instead of removing the entire nerve like a root canal, full pulpotomy removes only the inflamed pulp from the crown, preserving …
Phase: NA • Sponsor: King Abdullah University Hospital • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a smaller cut in robotic knee surgery mean less pain and faster healing?
Disease control Not yet recruitingThis trial is testing whether a minimally invasive technique for robotic knee replacement, which uses a smaller incision and less tissue disruption, can improve scar appearance and recovery compared to the standard approach. The study will involve 100 adults with knee osteoarthri…
Phase: NA • Sponsor: Hallym University Kangnam Sacred Heart Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a pill clear psoriasis on hands and feet?
Disease control Not yet recruitingThis trial tests whether an oral medication called zasocitinib (TAK-279) can reduce the redness, thickening, scaling, and painful cracks of palmoplantar psoriasis, a type of psoriasis that affects the palms and soles. Adults with moderate-to-severe non-pustular palmoplantar psori…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a new injection tame the painful lumps of hidradenitis suppurativa?
Disease control Not yet recruitingThis phase 2 trial tests whether an investigational medicine called SPY072 can improve hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps and tunnels. About 150 adults with moderate-to-severe HS who are already receiving standard care will be randomly a…
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug aims to tame autoimmune hepatitis and cut steroid use
Disease control Not yet recruitingThis study tests a drug called inebilizumab in 180 adults with autoimmune hepatitis, a condition where the immune system attacks the liver. The goal is to see if the drug can reduce liver inflammation and allow patients to take lower doses of steroids. Participants will receive e…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New knee implant under Real-World scrutiny: will it deliver better outcomes?
Disease control Not yet recruitingThis study follows about 1,020 people who receive the oneKNEE total knee prosthesis during knee replacement surgery. Researchers track safety and how well the implant works by measuring changes in knee pain and function using the Oxford Knee Score two years after surgery. The goa…
Sponsor: Aesculap AG • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug shows promise for lung scarring in Long-Term safety trial
Disease control Not yet recruitingThis study looks at the long-term safety of a drug called admilparant in people with pulmonary fibrosis (lung scarring). About 2,277 adults who finished earlier studies will take the drug and be monitored for side effects. The goal is to see if the drug is safe to use over time, …
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a common painkiller sabotage your knee treatment?
Disease control Not yet recruitingThis study tests whether taking ibuprofen after a platelet-rich plasma (PRP) injection changes pain relief and knee function in adults with knee osteoarthritis. Participants receive one ultrasound-guided PRP injection and then take either ibuprofen or acetaminophen for five days.…
Phase: NA • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a Once-Weekly pill clear stubborn psoriasis?
Disease control Not yet recruitingThis phase 2 trial is testing whether an experimental oral drug called HS-20118 can improve moderate to severe plaque psoriasis, a condition that causes thick, scaly patches on the skin. About 120 adults with the condition will receive either HS-20118 or a placebo once a week for…
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a new injection calm severe eczema when creams fall short?
Disease control Not yet recruitingThis study tests whether an investigational drug called tilrekimig, given as injections alongside medicated creams or ointments, can improve moderate-to-severe eczema (atopic dermatitis) in people aged 12 and older. Participants will be randomly assigned to receive either tilreki…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a 3D-Printed retainer keep your gums healthier after braces?
Disease control Not yet recruitingThis trial compares two types of clear retainers worn after braces to see if the way they are made affects gum health. One retainer is created from a digital scan of the teeth, while the other uses a traditional plaster mold. About 52 people who recently finished braces will wear…
Phase: NA • Sponsor: Ziauddin University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a new shoulder implant restore arm function where others fail?
Disease control Not yet recruitingThis study is following people who receive a Tornier Perform™ Reversed MonoPost shoulder replacement to see how well it works and how safe it is. The implant is designed for patients with severe shoulder damage, such as from arthritis, fractures, or failed previous surgeries. Res…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a gentler root canal save more tooth and still heal infection?
Disease control Not yet recruitingThis trial asks whether a minimally invasive root canal procedure can match the success of the traditional approach in treating lower molars with dead nerves and an infected root tip. Sixty adults aged 20 to 50 with such molars will be randomly assigned to receive either a conser…
Phase: PHASE2, PHASE3 • Sponsor: Mohamed Ashraf Abdeen • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can tiny silver particles supercharge root canal healing?
Disease control Not yet recruitingThis trial tests whether adding silver nanoparticles to a standard antibiotic paste used inside root canals can better reduce pain and inflammation in people with symptomatic apical periodontitis, a painful infection at the tooth root. Half of the 50 adult participants receive th…
Phase: NA • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a daily pill tame hepatitis d?
Disease control Not yet recruitingThis Phase 2 trial is testing an experimental oral drug called ABI-6250 in about 80 people with chronic hepatitis D, a serious liver infection. Participants take the pill once daily for 48 weeks. The study aims to see if the drug is safe, how it moves through the body, and whethe…
Phase: PHASE2 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new biologic calm severe eczema?
Disease control Not yet recruitingThis clinical trial is testing whether the drug nemolizumab can help treat moderate-to-severe atopic dermatitis (a common type of eczema) in Chinese patients aged 12 and older. Participants will receive either nemolizumab or a placebo (a look-alike with no active drug) every four…
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new pill quiet stubborn chronic hives?
Disease control Not yet recruitingThis phase II trial tests whether an experimental oral drug called TLL-018 can reduce itching and hives in adults with moderate-to-severe chronic spontaneous urticaria (CSU) that hasn't responded to standard antihistamines. Participants will take either a low or high dose of TLL-…
Phase: PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
AI could outsmart bacteria: a smarter way to choose antibiotics?
Disease control Not yet recruitingThis study tests whether a machine-learning system called iAST® can improve how doctors choose antibiotics for patients with pneumonia, urinary tract infections, or sepsis. The AI predicts which antibiotics are likely to work before standard lab results are available. Researchers…
Phase: NA • Sponsor: Instituto de Investigación Sanitaria Gregorio Marañón • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could a once-daily pill help children with fatty liver disease?
Disease control Not yet recruitingThis trial tests an experimental oral drug called resmetirom in children aged 6 to 17 with metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. The study aims to evaluate the drug's safety, how the body processes it, and its effects on the liver. Participan…
Phase: PHASE2 • Sponsor: Madrigal Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a laser and diabetes drug erase dark skin patches?
Disease control Not yet recruitingThis trial tests whether combining fractional carbon dioxide laser treatment with a topical metformin cream works better than laser alone for acanthosis nigricans—dark, velvety patches on the neck. About 34 adults with this condition will have one side of their neck treated with …
Phase: PHASE1 • Sponsor: Al-Azhar University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Navy beans take on fatty liver: a diet swap put to the test
Disease control Not yet recruitingThis trial tests whether replacing some of the usual diet with navy beans — without changing total calories — is a practical and acceptable way to help manage metabolic dysfunction-associated steatotic liver disease (MASLD) in adults with intermediate-stage liver fibrosis. Forty …
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new injection ease COPD and cut Flare-Ups?
Disease control Not yet recruitingThis trial is testing an investigational drug called brenipatide in adults with moderate-to-severe COPD. Participants will receive either brenipatide or a placebo for about a year, alongside standard care. The goal is to see if brenipatide improves lung function and reduces the n…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new pill tame ulcerative colitis?
Disease control Not yet recruitingThis early-stage trial is testing an experimental oral medication called HRS-7085 in adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The main goal is to see if the drug is safe and tolerable, and to understand how it moves through the body…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New trial aims to stop CMV eye inflammation from returning
Disease control Not yet recruitingThis study tests whether oral valganciclovir or ganciclovir eye drops can reduce the virus causing eye inflammation and prevent flare-ups. About 117 adults with CMV anterior uveitis will receive either antiviral treatment or placebo for 7 days, then some continue for 12 months. T…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a beam of light banish toenail fungus?
Disease control Not yet recruitingThis trial tests whether photodynamic therapy (PDT) can clear toenail fungus. People with a confirmed fungal nail infection will have a special gel applied to the affected nail, then exposed to red light. The study will check if the nail looks healthy and if the fungus is gone at…
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a new injection clear psoriasis when other biologics fail?
Disease control Not yet recruitingThis phase II trial is testing an investigational drug called SHR-1139 in adults with plaque psoriasis who have not responded well to at least one biologic treatment. Participants will receive either SHR-1139 or a placebo via subcutaneous injection over a 52-week treatment period…
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
Disease control Not yet recruitingSteroid injections for knee arthritis can temporarily raise blood sugar in people with type 2 diabetes. This trial tests whether giving a short course of NPH insulin right after the injection can prevent those high blood sugar episodes. Adults with type 2 diabetes and knee osteoa…
Phase: PHASE1, PHASE2 • Sponsor: Shifa International Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a gel under the gums regrow bone in diabetic gum disease?
Disease control Not yet recruitingThis trial tests whether applying a gel containing either metformin or zoledronate under the gums can improve healing of bone defects caused by periodontitis in people with well-controlled type 2 diabetes. Participants receive standard deep-cleaning treatment, and some also get o…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a new injection tame ulcerative colitis?
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called SHR-7590 to see if it is safe and tolerable when given by injection under the skin or into a vein. It involves healthy volunteers and people with moderate-to-severe ulcerative colitis, a condition that causes inflammat…
Phase: PHASE1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a gentler Deep-Clean beat standard gum therapy?
Disease control Not yet recruitingThis trial tests whether a minimally invasive deep-cleaning technique (MINST) works better than the usual scaling and root planing for severe periodontitis in back teeth. Adults aged 18–35 with stage III/IV gum disease will have one molar treated with standard cleaning and anothe…
Phase: NA • Sponsor: Ataturk University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a new Antibody-Lowering drug ease autoimmune brain inflammation?
Disease control Not yet recruitingThis Phase 2 trial tests efgartigimod PH20 SC, a drug that lowers harmful antibodies, in 170 adults and teens with autoimmune encephalitis (AIE). Participants receive either the drug or a placebo, and researchers measure changes in disability and symptoms over up to 3 years. The …
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could botox calm the painful skin flares of hidradenitis suppurativa?
Disease control Not yet recruitingThis phase 2 trial tests whether injecting botulinum toxin (Botox) into skin affected by hidradenitis suppurativa (HS) can reduce the number of painful abscesses, nodules, and draining tunnels, and ease pain. About 40 people with HS will receive either Botox or a saline placebo i…
Phase: PHASE2 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can engineered immune cells tame autoimmune kidney disease?
Disease control Not yet recruitingThis early-stage trial is testing whether a single infusion of universal STAR-T cells—a type of engineered immune cell that targets both CD19 and BCMA—can safely and effectively treat two autoimmune kidney diseases: IgA nephropathy and primary membranous nephropathy. The study wi…
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a toothpaste ingredient reshape the microbes behind gum disease?
Disease control Not yet recruitingThis trial tests whether a toothpaste containing arginine can alter the bacteria living below the gumline in people with gum disease who are already receiving ongoing dental care. Participants will brush twice daily for six months with either an arginine toothpaste or a standard …
Phase: NA • Sponsor: Sukirth M Ganesan, BDS, PhD • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a lung drug tame the pain of chronic pancreatitis?
Disease control Not yet recruitingThis phase 2 trial is testing whether pirfenidone, a drug already used for lung scarring, can help people with chronic pancreatitis—a long-term inflammation of the pancreas that causes severe pain. The study will enroll 60 adults with chronic pancreatitis and moderate-to-severe p…
Phase: PHASE2 • Sponsor: Vikas Dudeja • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a new injection match an existing eczema treatment?
Disease control Not yet recruitingThis trial is testing whether an experimental biologic called IBI3027 works as well as the approved drug dupilumab for people with moderate-to-severe atopic dermatitis (eczema). About 520 adults will be randomly assigned to receive either IBI3027 or dupilumab as a subcutaneous in…
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a diabetes drug improve joint replacement outcomes?
Disease control Not yet recruitingThis trial tests whether taking a GLP-1 medication (semaglutide) for at least six months before hip or knee replacement surgery can improve recovery and reduce complications in patients with obesity. Participants will be randomly assigned to receive either the medication plus beh…
Phase: PHASE4 • Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a probiotic keep ulcerative colitis in check?
Disease control Not yet recruitingThis trial is testing whether a probiotic supplement called Colipral, which contains a specific strain of E. coli bacteria, can improve gut health in people with ulcerative colitis who are in remission but still have digestive issues. Participants will take either the supplement …
Phase: NA • Sponsor: University of Padova • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a targeted antibody calm severe eczema?
Disease control Not yet recruitingThis first-in-human trial evaluates BYN-001, an antibody designed to block IL-25, a protein linked to atopic dermatitis (eczema). The study first tests the drug in healthy volunteers to assess safety and how it moves through the body, then in people with moderate to severe eczema…
Phase: PHASE1 • Sponsor: Bionyra Pharma • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a biologic drug calm the gut in ulcerative colitis? a Real-World trial seeks answers
Disease control Not yet recruitingThis study is testing whether guselkumab, a biologic drug, can help people with moderate-to-severe ulcerative colitis achieve remission. Participants receive IV infusions followed by maintenance injections. The trial tracks clinical, endoscopic, and histological healing over 48 w…
Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a new gel calm psoriasis Flare-Ups?
Disease control Not yet recruitingThis trial tests whether a topical gel called GM-XANTHO can reduce the severity of psoriasis, a chronic skin condition that causes red, scaly patches. About 65 adults with plaque psoriasis will apply the gel or a placebo daily for 28 days. Researchers will measure changes in skin…
Phase: PHASE2 • Sponsor: Xantho Biotechnology Co., LTD • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a simple phone call speed up tooth extraction recovery?
Disease control Not yet recruitingThis trial tests whether extra follow-up—via phone calls, digital messages, or both—helps people recover better after a tooth extraction. Adults having a tooth pulled will get standard instructions, and some will also receive structured phone or digital check-ins during the first…
Phase: NA • Sponsor: King Saud University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a new pill tame ulcerative colitis when others fail?
Disease control Not yet recruitingThis trial is testing an experimental oral drug called PTT-621 in adults aged 18-70 with moderate-to-severe ulcerative colitis who haven't responded well to standard treatments. Participants will take PTT-621 tablets for 12 weeks. The main goal is to see if the drug can improve t…
Phase: PHASE2 • Sponsor: Pyrotech Therapeutics, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a nerve pain drug boost bladder pain relief?
Disease control Not yet recruitingThis trial is testing whether adding the nerve pain medication pregabalin to a structured educational and behavioral program can better ease the symptoms of bladder pain syndrome (also called interstitial cystitis) than the program alone. Adults with this condition will be random…
Phase: PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Breathing workouts could give knee pain sufferers a leg up
Disease control Not yet recruitingThis trial tests whether adding inspiratory muscle training (IMT) — breathing exercises using a resistance device — to usual care can improve cardiopulmonary endurance and functional mobility in people with knee osteoarthritis. Adults aged 40-65 with bilateral knee osteoarthritis…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
One shot to ease knee pain? new gel injection put to the test
Disease control Not yet recruitingThis trial tests whether a single injection of a new gel, called 2107, can relieve pain and improve function in people with mild-to-moderate knee osteoarthritis. About 286 adults aged 40–80 will receive either 2107 or an existing hyaluronic acid injection (DUROLANE) directly into…
Phase: NA • Sponsor: BioRegen Biomedical (Changzhou) Co., Ltd • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a new pill tame ulcerative colitis? a First-in-Human trial aims to find out
Disease control Not yet recruitingThis early-stage trial evaluates an investigational oral drug called ONO-6414 in healthy adults and in people with active ulcerative colitis. The main goals are to assess the drug's safety, tolerability, and how the body processes it. The study includes single and multiple doses,…
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a disc made from donated tissue ease severe dry eye?
Disease control Not yet recruitingThis Phase 3 trial tests whether a disc made from donated human amnion membrane can help people with moderate to severe dry eye disease. The disc is placed on the eye and compared to standard care like lubricating drops and a bandage lens. The study will enroll 40 adults who have…
Phase: PHASE4 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new pill tame rheumatoid arthritis when standard drugs fail?
Disease control Not yet recruitingThis trial is testing an experimental drug called TLL-018 in adults with moderate-to-severe rheumatoid arthritis who haven't responded well to or couldn't tolerate standard treatments. Participants will receive either TLL-018 or a placebo for a period, and the study will measure …
Phase: PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Tailored breathing support may reduce lung injury in ECMO patients
Disease control Not yet recruitingThis study tests whether personalized ventilator settings can reduce lung injury in adults with severe respiratory failure who are on ECMO (a heart-lung machine). Researchers will use esophageal manometry or electrical impedance tomography to tailor the ventilator's positive pres…
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new drug tame VEXAS syndrome and cut steroid dependence?
Disease control Not yet recruitingThis phase 2 trial is testing whether an investigational drug called arumakimig can improve symptoms of VEXAS syndrome, a rare genetic autoinflammatory condition. The study will compare arumakimig against a placebo in about 120 adults with VEXAS, with the goal of seeing if the dr…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Body's own fat may offer new hope for chronic tendon pain
Disease control Not yet recruitingThis trial tests whether a one-time injection of a person's own concentrated fat can reduce pain and improve function in adults with chronic tendinopathy—tendon pain lasting more than three months that hasn't improved with usual treatments. Participants undergo a same-day procedu…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new pill slow kidney damage in IgA nephropathy?
Disease control Not yet recruitingThis study is testing whether an experimental drug called FXS6837 can safely reduce protein in the urine and help preserve kidney function in people with IgA nephropathy, a disease that can lead to kidney failure. About 60 patients who previously completed a shorter study of FXS6…
Phase: PHASE2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a single infusion tame tough lupus?
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called SNC116 in people with refractory systemic lupus erythematosus (SLE), a form of lupus that hasn't improved with standard treatments. The study aims to see if a single intravenous infusion of SNC116 is safe and tolerable…
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a common blood thinner shield psoriasis Patients' arteries?
Disease control Not yet recruitingThis trial tests whether antiplatelet medications, specifically clopidogrel and aspirin, can reduce inflammation in the blood vessels of people with psoriasis or psoriatic arthritis. Participants take each drug or a placebo for four weeks, and researchers measure changes in infla…
Phase: PHASE4 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a Real-World study reveal the staying power of guselkumab?
Disease control Not yet recruitingThis observational study tracks how long patients with moderate-to-severe Crohn's disease or ulcerative colitis continue taking guselkumab, a biologic treatment, in everyday clinical practice. Researchers will measure time until treatment discontinuation and early responses like …
Sponsor: Janssen Sciences Ireland UC • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new biologic calm the immune attack in ulcerative colitis?
Disease control Not yet recruitingThis early-stage trial is testing whether a drug called aletekitug is safe and tolerable for people with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The drug works by blocking a protein called IL-18, which may play a role in the inflammation that …
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a High-Protein, High-Fiber diet tame ulcerative colitis?
Disease control Not yet recruitingThis study will test whether a diet rich in protein and fiber can reduce harmful gas-producing bacteria in the gut of people with ulcerative colitis. Forty adults with mild to moderate disease will eat specially prepared frozen meals for two separate week-long periods. Researcher…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Coffee might boost gum Healing—A trial puts it to the test
Disease control Not yet recruitingThis trial asks whether daily caffeine intake can improve recovery after standard gum disease treatment. About 90 adults with periodontitis will receive non-surgical treatment and then be randomly assigned to avoid caffeine or consume low or moderate amounts for 6 months. Researc…
Phase: NA • Sponsor: Haoran Feng • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new biologic tame ulcerative colitis?
Disease control Not yet recruitingThis early trial is testing an experimental biologic drug called aletekitug in adults with moderate to severe ulcerative colitis. The main goal is to see if the drug is safe and tolerable when given repeatedly. Researchers will monitor side effects and changes in lab tests, vital…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a daily cocoa drink help keep blood vessels young?
Disease control Not yet recruitingThis trial tests whether taking a daily cocoa flavanol supplement for 4 to 8 weeks can improve blood vessel function and reduce inflammation in healthy men aged 30 to 75. Half the participants will receive the flavanol supplement, while the other half gets a low-flavanol control …
Phase: NA • Sponsor: The Black Forest LLC • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a pill tame ulcerative colitis? new trial seeks answers
Disease control Not yet recruitingThis early-stage trial is testing an experimental oral medication called Alpha-0261 in about 10 adults with moderate to severe ulcerative colitis. The main goal is to check the drug's safety and tolerability, while also looking at whether it can help reduce symptoms and lead to c…
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a targeted antibody tame kidney inflammation without heavy steroids?
Disease control Not yet recruitingThis phase 2 trial is testing whether a new drug called obinutuzumab beta, combined with a short course of steroids, can help people with newly diagnosed ANCA-associated glomerulonephritis—a rare autoimmune disease that causes kidney inflammation and damage. The study will enroll…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a 'No-Cut' gum surgery regrow lost bone?
Disease control Not yet recruitingThis trial tests a new surgical technique that avoids cutting the gum tissue between teeth to repair deep bone defects caused by gum disease. The procedure uses a synthetic bone graft and a special gel to help the bone regenerate. The study includes 60 adults aged 35 to 65 with a…
Phase: PHASE1, PHASE2 • Sponsor: Mansoura University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could a shorter drug course beat a longer one for a deadly fungal infection?
Disease control Not yet recruitingThis trial is testing whether a 10-week course of fluconazole works as well as the standard 24-week course for people with HIV who have a cryptococcal infection in their blood (antigenemia) but no symptoms. It also compares starting HIV medications right away versus waiting 14 da…
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a targeted antibody stop severe hepatitis from destroying Children's livers?
Disease control Not yet recruitingThis trial tests whether a medicine called emapalumab, which calms a specific part of the immune system, can prevent liver failure in children aged 1 year and older with severe hepatitis that hasn't improved with steroids. The study includes a screening group to observe all sever…
Phase: PHASE2 • Sponsor: Children's Healthcare of Atlanta • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug cocktail aims to clear stubborn hand and foot pustules
Disease control Not yet recruitingThis Phase 3 trial tests whether combining two drugs, tofacitinib and imatinib, can safely clear the painful pustules of palmoplantar pustulosis (PPP), a rare chronic skin disease on the palms and soles. About 135 adults with moderate-to-severe PPP will receive either the combo o…
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Blood thinner may stop organ failure in pancreatitis patients
Disease control Not yet recruitingThis study tests whether giving the blood thinner heparin early can prevent organ failure in people hospitalized with acute pancreatitis. The inflammation from pancreatitis can cause tiny blood clots that damage organs like the lungs and kidneys. Half of the 100 participants will…
Phase: PHASE4 • Sponsor: Allied Hospital Faisalabad • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a simple electrical boost improve posture after knee surgery?
Disease control Not yet recruitingThis trial tests whether adding electrical stimulation to the lower back muscles, alongside standard rehabilitation, can improve spine and pelvis alignment after total knee replacement surgery. People aged 40-80 with knee osteoarthritis and measurable spinal misalignment will be …
Phase: NA • Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a pill outperform biologics for severe eczema?
Disease control Not yet recruitingThis study looks at how well upadacitinib, a daily pill, works compared to biologic injections for people with moderate-to-severe atopic dermatitis (eczema). The goal is to see if more patients can reach a state of minimal disease activity, meaning nearly clear skin and little to…
Sponsor: AbbVie • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Which knee surgery approach gets you back on your feet faster?
Disease control Not yet recruitingThis trial compares two surgical techniques for total knee replacement—the subvastus approach and the medial parapatellar approach—to see which one leads to better recovery and function. The study will enroll 84 people with severe knee osteoarthritis who need a knee replacement. …
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new pill tame psoriasis? early safety trial begins
Disease control Not yet recruitingThis early-stage trial is testing an experimental oral drug called HL40626S in healthy adults aged 18 to 55. The goal is to check the drug's safety, how the body processes it, and the best dose range. If it passes these initial safety checks, the drug could eventually be studied …
Phase: PHASE1 • Sponsor: HighsLab Therapeutics Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new eye drop soothe severe dry eye?
Disease control Not yet recruitingThis clinical trial is testing whether an experimental eye drop called OT202 can improve symptoms and repair the eye surface in people with moderate to severe dry eye. About 842 adults aged 30 to 75 with a history of dry eye will receive either OT202 or a placebo drop three times…
Phase: PHASE3 • Sponsor: Ocumension Therapeutics (Suzhou) Co., Ltd • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a higher dose of upadacitinib rescue ulcerative colitis patients when standard treatment fails?
Disease control Not yet recruitingThis study tests whether a temporary higher dose of upadacitinib (45 mg daily) can bring ulcerative colitis back under control in adults whose disease flared up while on the standard 30 mg maintenance dose. Participants receive the higher dose for 8 to 16 weeks, then may step dow…
Phase: PHASE4 • Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a tiny gum graft boost tooth-saving surgery?
Disease control Not yet recruitingThis trial tests whether adding a small piece of connective tissue from the roof of the mouth to a standard gum-saving surgery helps repair deep bone defects caused by gum disease. Thirty adults with two or more deep gum pockets will receive the surgery on both defects, but only …
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a biologic drug safely tame Back-Joint inflammation? a Real-World trial investigates
Disease control Not yet recruitingThis study tracks the safety of secukinumab, a biologic injection, in Indian adults with axial spondyloarthritis — a group of inflammatory conditions that cause back pain and stiffness. Over 16 weeks, researchers will monitor side effects and disease activity in about 60 particip…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Antibiotics vs. placebo for Kids' sinus infections: which works best?
Disease control Not yet recruitingThis trial tests whether common antibiotics—amoxicillin or amoxicillin-clavulanate—actually reduce symptoms in children aged 2 to 12 with acute sinusitis. About 1,100 children are randomly assigned to one of the two antibiotics or a placebo, and parents track daily symptoms. The …
Phase: PHASE4 • Sponsor: Nader Shaikh • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Muscle loss may slow hip replacement recovery — a trial tests whether exercise can help
Disease control Not yet recruitingThis trial tests whether screening older adults for sarcopenia (loss of muscle strength and mass) before hip replacement surgery, followed by a structured exercise program after surgery, can improve recovery. Participants aged 65 and older with advanced hip osteoarthritis will be…
Phase: NA • Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Gut bacteria swap may tame diabetes and thyroid disease
Disease control Not yet recruitingThis trial tests whether a one-time dose of fecal microbiota transplantation (FMT) — taking capsules containing processed donor stool — can improve blood sugar control and reduce thyroid antibodies in adults who have both type 2 diabetes and Hashimoto's thyroiditis. All 38 partic…
Phase: PHASE4 • Sponsor: Shen Xujun • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a prostate drug stop shoulder infections before they start?
Disease control Not yet recruitingThis trial tests whether finasteride, a drug that blocks testosterone production, can reduce levels of Cutibacterium acnes bacteria on the skin. High testosterone is linked to more of this bacteria, which can cause serious infections during shoulder replacement surgery. Healthy m…
Phase: PHASE4 • Sponsor: University of Washington • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a heart drug tame rheumatoid arthritis?
Disease control Not yet recruitingThis trial tests whether nicorandil, a drug currently used for heart conditions, can reduce disease activity and symptoms in people with rheumatoid arthritis. About 70 adults with moderate-to-severe RA will take either nicorandil or a placebo twice daily for three months, while c…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a gene-silencing drug calm overactive complement in kidney disease?
Disease control Not yet recruitingThis phase II trial tests an experimental drug called QLS7305 in people with several kidney diseases driven by overactivation of the complement system, a part of the immune system. The drug is a small interfering RNA (siRNA) designed to reduce production of complement protein C3,…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can engineered immune cells tame stubborn autoimmune diseases?
Disease control Not yet recruitingThis phase 1 trial tests an experimental cell therapy called LMY-922 (BAFF CAR-T cells) in people aged 16 to 75 with refractory autoimmune diseases, including rheumatoid arthritis, lupus, dermatomyositis, and systemic sclerosis. The therapy uses donor immune cells engineered to t…
Phase: PHASE1 • Sponsor: Luminary Therapeutics • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a single gene therapy injection reverse fatty liver disease?
Disease control Not yet recruitingThis trial tests an experimental gene therapy called VV-14303 for people with metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition linked to obesity and diabetes. The therapy uses a harmless virus to deliver a protein (FGF21) that may improve liver h…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a new pill prevent esophageal damage from returning?
Disease control Not yet recruitingThis trial tests whether an experimental drug called JP-1366 can prevent the return of erosive esophagitis in people whose condition has already healed. About 384 adults aged 19 to 75 will take either JP-1366 or the standard drug lansoprazole daily for 24 weeks. The goal is to se…
Phase: PHASE3 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a single cream tackle both skin and nail psoriasis?
Disease control Not yet recruitingThis trial tests whether a daily application of roflumilast 0.3% cream can improve both chronic plaque psoriasis and moderate-to-severe nail psoriasis. People aged 12 and older with stable disease for at least 6 months apply the cream to affected nails and plaques daily for 24 we…
Phase: PHASE4 • Sponsor: Modern Research Associates, PLLC • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Ancient herbs vs. superbugs: can TCM prevent repeat pneumonia?
Disease control Not yet recruitingThis study follows over 500 hospitalized adults with drug-resistant bacterial pneumonia to see whether those who receive systemic traditional Chinese medicine (such as herbal decoctions or injections) have fewer lower respiratory tract infections in the six months after leaving t…
Sponsor: Henan University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Ear infection dilemma: do antibiotics work better than a placebo for young children?
Disease control Not yet recruitingThis trial investigates whether antibiotics like amoxicillin or amoxicillin-clavulanate ease symptoms of ear infections (acute otitis media) in children aged 6 months to 3 years better than a placebo. Over 1,100 children are randomly assigned to one of three groups, and families …
Phase: PHASE4 • Sponsor: Nader Shaikh • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug combo aims to shield Children's hearts from kawasaki disease
Disease control Not yet recruitingThis study tests whether adding a drug called firsekibart to the standard treatment (IVIG and aspirin) can better prevent coronary artery damage in children with Kawasaki disease. Kawasaki disease causes inflammation in blood vessels, especially those supplying the heart, and can…
Phase: PHASE2, PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a new daily pill slow lung scarring in IPF?
Disease control Not yet recruitingThis phase 2 trial tests whether an experimental drug called HSK50042 can improve lung function in adults with idiopathic pulmonary fibrosis (IPF), a chronic condition that causes lung scarring and breathing difficulties. Participants take HSK50042 or a placebo once daily for 26 …
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New gastritis drug candidate tested in three formulations to find the best acid controller
Disease control Not yet recruitingThis trial tests three different tablet versions of an experimental drug called AD-234 in healthy adults aged 19 to 50. The goal is to see which formulation best controls stomach acid levels over 24 hours after a week of daily dosing. Researchers will also compare how the body ab…
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Ancient herbs meet modern medicine: can Curcumin-QingDai tame UC?
Disease control Not yet recruitingThis study tests whether adding a combination of curcumin (from turmeric) and QingDai (a traditional Chinese herb) to standard vedolizumab treatment can help people with moderate to severe ulcerative colitis reach remission. About 160 adults will receive either the herbal combo o…
Phase: PHASE4 • Sponsor: Ryan C Ungaro • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
AI takes the wheel: could a computer outthink doctors on ventilator settings for kids?
Disease control Not yet recruitingThis trial tests whether an AI system can help doctors choose better ventilator settings for children (ages 1 month to 18 years) in the pediatric ICU who need a breathing machine. Half of the children will receive standard care, while the other half will have their ventilator adj…
Phase: NA • Sponsor: Wu Rongzhou • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a new daily pill quiet the immune attack behind psoriasis?
Disease control Not yet recruitingThis phase 3 trial is testing an experimental daily capsule called TQH3906 in adults with moderate to severe plaque psoriasis. The drug works by blocking a key immune pathway involved in skin inflammation. Researchers are comparing TQH3906 against a placebo and an approved treatm…
Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Immune cell therapy aims to stop BK virus bladder bleeding in transplant patients
Disease control Not yet recruitingThis early-phase trial tests a new treatment called LB-DTK-BKV for people who develop painful bladder bleeding (hemorrhagic cystitis) from BK virus after a stem cell transplant. The treatment uses immune cells from a donor that are trained to attack the virus. About 42 children a…
Phase: PHASE1, PHASE2 • Sponsor: LucasBio • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a single drug calm lupus kidney disease without a cocktail of meds?
Disease control Not yet recruitingThis phase II trial tests whether obinutuzumab, a B-cell targeting antibody, can alone achieve complete kidney response in people with pure class V lupus nephritis—a form of lupus kidney disease with no approved treatments. Participants receive up to four infusions over seven mon…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
A pharmacist in the dentist's chair: could a new team approach tame stubborn mouth conditions?
Disease control Not yet recruitingThis trial tests whether adding a clinical pharmacist to dental care can improve how oral mucosal disorders — such as oral lichen planus, recurrent canker sores, burning mouth syndrome, oral thrush, and herpes infections — are managed. Dentists in some clinics will get pharmacist…
Phase: NA • Sponsor: University of Fujairah • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can an experimental injection clear stubborn psoriasis? a new trial aims to find out.
Disease control Not yet recruitingThis phase 2 trial tests whether the experimental drug SHR-1139 can improve skin clearance in adults with moderate to severe plaque psoriasis. About 60 participants will receive either SHR-1139 or a placebo over 52 weeks. The main goal is to see how many achieve complete skin cle…
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a new drug slow lung scarring in IPF?
Disease control Not yet recruitingThis phase 3 trial is testing whether an experimental drug called AK3280 can slow the decline in lung function for people with idiopathic pulmonary fibrosis (IPF), a condition that causes progressive lung scarring. About 263 adults aged 40 and older with IPF will receive either A…
Phase: PHASE3 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can ulcerative colitis patients in remission ditch their daily pill?
Disease control Not yet recruitingThis trial asks whether adults with ulcerative colitis who are in deep remission can safely stop taking their JAK inhibitor medication (tofacitinib, upadacitinib, or filgotinib) instead of continuing daily maintenance therapy. Half of the 224 participants will stop treatment and …
Phase: PHASE4 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could bone marrow PRP heal tennis elbow better than blood PRP?
Disease control Not yet recruitingThis trial compares two types of platelet-rich plasma (PRP) injections for people with tennis elbow that hasn't improved with standard treatments. One injection uses PRP made from the patient's own bone marrow, while the other uses PRP from their blood. The study aims to see if t…
Phase: NA • Sponsor: Clinique du Sport, Bordeaux Mérignac • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a weekly shot help more people donate part of their liver?
Disease control Not yet recruitingThis study tests whether a 12-week program combining a weekly injection of mazdutide (a drug that targets gut hormones) with lifestyle counseling can quickly reduce liver fat in overweight or obese people who want to donate part of their liver but are temporarily disqualified due…
Phase: PHASE2, PHASE3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Gut and mouth bacteria may predict who benefits from probiotics for gum disease
Disease control Not yet recruitingThis study investigates whether a daily probiotic lozenge containing Limosilactobacillus reuteri can reduce inflammation and improve gum health in adults with severe periodontal disease. Researchers will also analyze participants' oral and gut bacteria to identify who is most lik…
Phase: NA • Sponsor: University of New Hampshire • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Robot or Surgeon's hand? trial tests which knee replacement heals faster
Disease control Not yet recruitingThis trial compares robotic-assisted total knee replacement to the conventional manual approach in adults with knee osteoarthritis. All participants follow the same structured home-based rehabilitation program before and after surgery. The study measures knee pain, function, and …
Phase: NA • Sponsor: Mark Hurworth • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Smartphone Follow-Up could replace hospital stays after common surgeries
Disease control Not yet recruitingThis study tests whether sending patients home on the same day of surgery, with follow-up care via phone calls, home visits, and a mobile app, is as safe and less costly than keeping them in the hospital overnight. The trial includes adults in Uganda having low-risk procedures su…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could your own blood cells ease knee arthritis pain?
Disease control Not yet recruitingThis clinical trial tests whether injecting a person's own purified blood cells into the knee can reduce pain and improve movement in people with knee osteoarthritis. The study compares two doses of these cells against a standard steroid injection. Participants are adults aged 40…
Phase: PHASE2, PHASE3 • Sponsor: DuoGenic StemCells Corporation (DGSC) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Simple betadine wash before C-Section may slash infection risk
Disease control Not yet recruitingThis trial tests whether cleaning the vagina with a betadine solution for 30 seconds just before a cesarean section can lower the chance of wound infections, fever, and uterine infection after surgery. About 600 women having either planned or emergency C-sections will take part. …
Phase: NA • Sponsor: Mohamed Mousa Mohamed Mousa • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a common antibiotic boost eczema treatment?
Disease control Not yet recruitingThis trial investigates whether adding the antibiotic azithromycin to standard topical creams (betamethasone or tacrolimus) improves eczema symptoms in children aged 3 to 12 with mild to moderate atopic dermatitis. Researchers will measure changes in the Eczema Area and Severity …
Phase: PHASE4 • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Laser boost for stubborn psoriasis on hands and feet
Disease control Not yet recruitingThis study compares two treatments for palmoplantar psoriasis, a form of psoriasis affecting the palms and soles. One group receives a topical steroid cream alone, while the other receives the same cream plus a fractional CO2 laser treatment every four weeks. The goal is to see i…
Phase: PHASE4 • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a new mouthwash help kids with braces fight plaque and bad breath?
Disease control Not yet recruitingThis study tests whether a new, chlorhexidine-free mouthwash can reduce plaque buildup, gum inflammation, and bad breath in children aged 12 to 17 who wear fixed metal braces. Participants rinse twice daily for 21 days alongside their usual brushing and flossing. The trial compar…
Phase: NA • Sponsor: Plovdiv Medical University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Smart bottle cap could reveal hidden missed doses in GERD patients
Disease control Not yet recruitingThis study tests whether a digital bottle cap called FORTISKAP™ can detect missed doses of proton pump inhibitors (PPIs) in people with GERD more accurately than standard methods like pharmacy fill records or patient questionnaires. Fifty adults with GERD who take a daily PPI wil…
Phase: NA • Sponsor: Cosmos Rx, Inc • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Veggies first, carbs last: could meal and exercise order be the key to childhood weight loss?
Disease control Not yet recruitingThis trial tests whether changing the order of exercise (aerobic before anaerobic, or vice versa) and the order of eating (vegetables and protein first, carbohydrates last) helps overweight children and teens lose weight and improve health. Over 28 days at a weight loss camp, par…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Experimental drug aims to tackle both obesity and knee arthritis
Disease control Not yet recruitingThis phase 3 trial tests an injectable drug called ribupatide in people who have both obesity and knee osteoarthritis. The study measures whether ribupatide can reduce knee pain and stiffness, improve joint function, and help with weight loss over 68 weeks. Participants are rando…
Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could fewer plasma exchange sessions be just as effective for kids with brain inflammation?
Disease control Not yet recruitingThis trial tests whether plasma exchange (a blood-cleaning procedure) given every other day works as well as daily sessions for children with autoimmune encephalitis, a condition where the immune system attacks the brain. The study involves 22 children who are randomly assigned t…
Phase: NA • Sponsor: Menoufia University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Not yet recruitingThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Phase: PHASE4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New daily pill aims to tame psoriatic arthritis symptoms
Disease control Not yet recruitingThis phase 2 trial tests an experimental oral drug called CBP-0276 in adults with active psoriatic arthritis, a condition causing joint pain, swelling, and skin plaques. Participants receive either a low dose (200 mg), a high dose (800 mg), or a placebo daily for 24 weeks. The ma…
Phase: PHASE2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a common herb ease rheumatoid arthritis?
Disease control Not yet recruitingThis study investigates whether ginkgo biloba extract can improve outcomes for people with moderate to severe rheumatoid arthritis who are already on standard disease-modifying drugs. Participants take ginkgo biloba for 12 weeks, and researchers measure changes in inflammation ma…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Ancient chewing stick could rival toothbrush for gum health
Disease control Not yet recruitingThis trial compares a standardized siwak (chewing stick) oral hygiene program to conventional toothbrushing for improving gum health in young adults with gingivitis. Participants are dental students aged 18–24 who will follow either the siwak module or toothbrushing for 21 days. …
Phase: NA • Sponsor: National University of Malaysia • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Real-World study tests Once-Daily pill for ulcerative colitis in chinese adults
Disease control Not yet recruitingThis study looks at how the oral medication etrasimod works for Chinese adults with active ulcerative colitis (UC) in real-world settings. About 500 participants will take etrasimod as part of their routine care and be followed for at least 52 weeks. Researchers will track change…
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Coconut oil takes on chlorhexidine in gum disease showdown
Disease control Not yet recruitingThis study compares virgin coconut oil mouthwash to the standard chlorhexidine mouthwash as an add-on to deep cleaning for people with stage II periodontitis (gum disease). Over 30 days, researchers measure gum health indicators like pocket depth, bleeding, and inflammation. They…
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Friendly bacteria cream could soothe childhood eczema
Disease control Not yet recruitingThis study tests whether a probiotic ointment (containing live, friendly bacteria) can improve eczema in children aged 6 months to 15 years. The ointment is compared to a basic lotion over 28 days. Researchers measure skin redness, itching, and skin barrier function to see if the…
Phase: NA • Sponsor: BioGaia AB • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a lower dose of a common antibiotic be safer and just as effective for a deadly pneumonia?
Disease control Not yet recruitingThis study looks at whether a lower dose of the antibiotic TMP-SMX works as well as the standard dose for treating a serious lung infection called Pneumocystis pneumonia (PCP) in people who do not have HIV. The standard dose often causes side effects in more than half of patients…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Magnetic heat zaps infection in knee implants without removal
Disease control Not yet recruitingThis trial tests whether a device that uses alternating magnetic fields to heat metal knee implants can help treat infections without removing the implant. Adults with a knee implant infection receive surgery, antibiotics, and either active or sham magnetic treatment. The study m…
Phase: NA • Sponsor: Solenic Medical, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a simpler eczema routine boost treatment success?
Disease control Not yet recruitingThis study explores whether giving people with mild-to-moderate eczema a straightforward treatment plan using only Opzelura cream helps them stick to their medication routine. Participants apply the cream twice daily until their skin clears, then as needed. Some participants also…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Vaginal device aims to boost infection treatment
Disease control Not yet recruitingThis study tests whether a vaginal ovule device, used alongside standard antibiotics or antifungals, improves vaginal health in women with bacterial vaginosis or yeast infections. Eighty women aged 18 to 60 receive either the active device or a placebo ovule over three treatment …
Phase: NA • Sponsor: ROELMI HPC • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a common diabetes drug help muscles heal faster after ACL surgery?
Disease control Not yet recruitingThis study investigates whether metformin, a widely used diabetes medication, can help muscles recover better after anterior cruciate ligament (ACL) reconstruction surgery. The trial enrolls adults aged 40 and older with a full ACL tear who are scheduled for surgery. Participants…
Phase: EARLY_PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Blue light could soothe vaginal disorders without hormones
Disease control Not yet recruitingThis study tests whether blue LED light therapy can improve symptoms of common vaginal conditions like menopause-related dryness, bacterial vaginosis, and yeast infections. About 150 women aged 18 to 75 will receive the treatment either at home or in a clinic. Researchers will ch…
Phase: NA • Sponsor: Patricia Lordelo • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Cooling the pancreas from the inside: a new device aims to tame severe inflammation
Disease control Not yet recruitingThis trial tests whether a special cooling tube placed near the pancreas can help people with acute pancreatitis recover faster. Participants are randomly assigned to receive either standard care alone or standard care plus the cooling device for up to three days. The study measu…
Phase: NA • Sponsor: Arctx Medical, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could fewer injections keep kids' eye inflammation in check?
Disease control Not yet recruitingThis trial investigates whether children and young adults with juvenile idiopathic arthritis (JIA)-related uveitis can safely take adalimumab injections less frequently without their eye or joint inflammation returning. Participants are assigned to receive injections every 2, 4, …
Phase: PHASE4 • Sponsor: Nisha Acharya • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Fungal enzymes could replace pig enzymes for digestive aid in pancreatitis
Disease control Not yet recruitingThis trial compares fungal-based pancreatic enzymes to standard pig-derived enzymes in people with chronic pancreatitis and digestive insufficiency. Participants take either the fungal or porcine enzyme for 12 weeks to see if the fungal version works just as well. The goal is to …
Phase: PHASE3 • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Community health workers may boost antibiotic adherence for rheumatic heart disease
Disease control Not yet recruitingThis study tests whether community health workers (CHWs) can help people with rheumatic heart disease (RHD) take their monthly antibiotic shots consistently. The trial will enroll about 308 participants in Brazil and Timor-Leste, including adults and children with RHD and their c…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could Two-Drug cocktails tame stubborn inflammatory bowel disease?
Disease control Not yet recruitingThis study tests whether combining risankizumab with either trosunilimab or ABBV-701 can safely reduce inflammation and improve symptoms in adults with moderately to severely active Crohn's disease or ulcerative colitis. Participants are randomly assigned to one of the combinatio…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
One or two infusions could replace weeks of antibiotics for heart infection
Disease control Not yet recruitingThis study compares a long-acting antibiotic called dalbavancin to standard therapy for treating infective endocarditis, a serious infection of the heart valves caused by certain bacteria. Dalbavancin is given as one or two intravenous infusions, while standard therapy requires d…
Phase: PHASE3 • Sponsor: Stefan Hagel • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Viruses that eat bacteria could help save infected joint replacements
Disease control Not yet recruitingThis trial investigates whether adding bacteriophages—viruses that specifically target and kill bacteria—to standard surgery and antibiotics can improve outcomes for people with infected hip or knee replacements. The study enrolls adults with an infection caused by Staphylococcus…
Phase: PHASE2, PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Weekly shot aims to tame dangerous fat levels in the blood
Disease control Not yet recruitingThis Phase 3 trial tests an investigational biologic called DR10624, given as a weekly injection, in adults with severe hypertriglyceridemia (very high blood fats) who are already on standard lipid-lowering therapy. The study compares two doses of DR10624 against a placebo to see…
Phase: PHASE3 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental drug aims to tame rare nerve disorder
Disease control Not yet recruitingThis trial tests a drug called obinutuzumab β in people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), a condition where the immune system attacks nerves, causing weakness and numbness. Participants receive two intravenous infusions of the drug and are mon…
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Virtual program aims to keep joint replacement patients moving while they wait
Disease control Not yet recruitingThis study tests a 3-month virtual program called Choose to Move Replacement Ready for people on waitlists for hip or knee replacement due to osteoarthritis. The program offers choice-based physical activity and group support to help participants stay active, reduce pain, and imp…
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a structured recovery plan speed healing after emergency gallbladder surgery?
Disease control Not yet recruitingThis study tests whether a standardized care pathway called RICA helps people recover faster after emergency keyhole surgery for moderate gallbladder inflammation (Grade II acute cholecystitis). The pathway includes steps like ultrasound before surgery, limited fasting, blood sug…
Phase: NA • Sponsor: Hospital d'Igualada • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a simple blood test allow uveitis patients to safely take less medication?
Disease control Not yet recruitingThis trial investigates whether people with chronic non-infectious uveitis—an eye condition that can cause blindness—can safely reduce their dose of adalimumab (a drug that calms the immune system) by using regular blood tests to monitor drug levels. Participants whose uveitis ha…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental drug aims for functional cure in hepatitis b
Disease control Not yet recruitingThis phase 2 study tests whether the drug bepirovirsen can achieve a functional cure for chronic hepatitis B in 30 adults with low virus levels. Participants receive weekly injections for 24 weeks and undergo liver biopsies to measure changes in the virus and immune response. The…
Phase: PHASE2 • Sponsor: National University Health System, Singapore • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Foam could ease painful skin lumps in hidradenitis suppurativa
Disease control Not yet recruitingThis study tests a medicated foam called roflumilast applied daily to hidradenitis suppurativa (HS) lesions for 16 weeks. It includes adolescents and adults with mild to moderate HS (Hurley stage I or II) who have 4 to 10 painful lumps or abscesses but no draining tunnels. The ma…
Phase: PHASE2 • Sponsor: Harrison Dermatology • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can stem cell exosomes heal Radiation-Damaged bladders?
Disease control Not yet recruitingThis early-phase trial tests whether a combination of stem cell exosomes and sodium hyaluronate, instilled directly into the bladder, can safely treat radiation cystitis—a painful condition causing bleeding and urinary problems after pelvic radiotherapy. 48 women aged 18-80 will …
Phase: EARLY_PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a special toothpaste replace the Dentist's scraper?
Disease control Not yet recruitingThis trial tests a new toothpaste containing a Bio-Descaling Powder (BDP) to see if it can reduce hardened dental plaque (calculus) and gum inflammation. It includes 100 adults with gum disease or who are in a gum maintenance program. Participants brush with either the BDP toothp…
Phase: NA • Sponsor: Universidad Complutense de Madrid • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Short implants, long promise: 5-Year study tests durability in tough jaw spots
Disease control Not yet recruitingThis study follows 100 adults who received short dental implants (7 or 8 mm) in the back part of the upper or lower jaw. Researchers want to see how well these implants hold up over 5 years by measuring bone loss, stability, and overall success. The goal is to determine if shorte…
Sponsor: University of Guarulhos • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could early treatment tame a painful skin condition?
Disease control Not yet recruitingThis study looks at whether starting secukinumab early in people with moderate-to-severe hidradenitis suppurativa (a chronic skin condition causing painful lumps) can slow disease progression. Researchers will analyze data from existing medical records and registries across Europ…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Ancient chewing stick put to the test against gum disease
Disease control Not yet recruitingThis study looks at whether using a miswak stick—a natural teeth-cleaning twig—along with regular brushing can improve gum health in people with gingivitis. Researchers will measure markers of inflammation and oxidative stress in saliva and plaque. The goal is to see if this trad…
Sponsor: Mustafa Kemal University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a three-day pill course after joint replacement speed up recovery?
Disease control Not yet recruitingThis trial tests whether taking the anti-bleeding medication tranexamic acid (TXA) for three days after hip or knee replacement surgery helps people recover faster and with less pain. Adults with osteoarthritis who are having a first-time joint replacement receive either TXA or a…
Phase: PHASE4 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New Wound-Cleaning method may let surgeons close incisions right away after severe appendicitis
Disease control Not yet recruitingThis trial tests whether closing the surgical wound immediately after cleaning it with a special high-pressure irrigation technique (HIEDI) is as good as or better than waiting a few days to close it. The study involves 200 people aged 12 and older who have open surgery for compl…
Phase: NA • Sponsor: Sana'a University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a common fruit replace harsh chemicals in root canals?
Disease control Not yet recruitingThis study tests whether amla (Emblica officinalis), a medicinal plant, can replace standard sodium hypochlorite as a disinfectant during root canal treatment. The trial includes 66 people aged 18–50 with infected single-rooted front teeth. Researchers measure how well each solut…
Phase: NA • Sponsor: Postgraduate Medical Institute, Lahore • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could probiotics stop a deadly infection from coming back in liver disease?
Disease control Not yet recruitingThis study tests whether adding a probiotic (Bifidobacterium quadruple live tablets) to standard antibiotics can better control and prevent the return of spontaneous bacterial peritonitis (SBP) in people with cirrhosis. SBP is a serious infection of the abdominal fluid that often…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
AI-Designed drug targets scarred lungs in major trial
Disease control Not yet recruitingThis phase 3 trial tests whether the oral drug rentosertib (INS018_055) can slow lung function decline in adults with idiopathic pulmonary fibrosis (IPF), a progressive lung disease. About 320 participants will receive either rentosertib or a placebo daily for 52 weeks. The main …
Phase: PHASE3 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New oral drug aims to tame ulcerative colitis Flare-Ups
Disease control Not yet recruitingThis trial tests whether the oral drug ponesimod can help people with moderately to severely active ulcerative colitis achieve remission. Participants receive either ponesimod or a placebo daily for 16 weeks, with an option to continue on ponesimod for another 36 weeks. The study…
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a tailored diet make a MASH drug work better?
Disease control Not yet recruitingThis study tests whether adding a Mediterranean-style meal delivery program to resmetirom therapy improves liver health more than resmetirom alone. It involves 120 adults with non-cirrhotic MASH who are starting resmetirom. Participants either receive the drug plus 10 medically t…
Phase: PHASE4 • Sponsor: City University of New York • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Cheaper plasma treatment may rival albumin for kidney swelling in kids
Disease control Not yet recruitingThis study compares two treatments—albumin and fresh frozen plasma—for children with idiopathic nephrotic syndrome who have fluid buildup that doesn't respond to standard diuretics. The goal is to see which approach resolves swelling faster and more safely. Fifty-six children age…
Phase: NA • Sponsor: Qamar Shafiq • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill aims to tame rheumatoid arthritis inflammation
Disease control Not yet recruitingThis study tests an experimental oral drug called JAB-8263 in adults with active rheumatoid arthritis. The goal is to see if it is safe and can reduce joint inflammation and pain. Participants take the drug or a placebo every other day for 28 days. The trial is small and early-st…
Phase: PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New foam could tame stubborn scalp and face rash
Disease control Not yet recruitingThis trial tests whether a once-daily foam containing roflumilast can treat seborrheic dermatitis, a common skin condition causing red, flaky patches on the scalp, face, and trunk. About 300 people ages 9 and older with moderate to severe disease will apply either the active foam…
Phase: PHASE3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Cancer drug repurposed to calm brain inflammation in autoimmune disease
Disease control Not yet recruitingThis study tests whether a low dose of blinatumomab, a drug originally used for leukemia, can help people with severe autoimmune encephalitis or cerebellitis that hasn't responded to standard treatments. The drug targets and depletes certain immune cells (B cells) that are mistak…
Phase: PHASE4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Cream-and-Steroid combo aims to recolor vitiligo patches
Disease control Not yet recruitingThis study tests whether a cream containing ruxolitinib (Opzelura) combined with corticosteroid injections or pills can improve facial vitiligo. It includes people aged 12 and older with active, non-segmental vitiligo affecting the face. Participants use the cream twice daily and…
Sponsor: ShanShan Li • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Faster, better baby tooth root canals? trial pits two rotary file systems Head-to-Head
Disease control Not yet recruitingThis trial compares two types of rotary files designed for children's primary molars: Fanta AF Baby and EndoArt Pedo Blue. The goal is to see which system prepares root canals faster and with better filling quality during a pulpectomy (removing infected pulp). Thirty children age…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already approved for eczema, can help people who have both atopic dermatitis (a type of eczema) with moderate to severe itching and a hard-to-treat autoimmune liver disease called cholangitis. The drug works by blocking a pathway invo…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New dialysis filter aims to cut inflammation and protect hearts in kidney patients
Disease control Not yet recruitingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can reduce inflammation and improve heart function better than the standard filter in people with end-stage kidney disease. Thirty adults on maintenance hemodialysis will use each filter for three …
Phase: NA • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple knee sleeve slow arthritis and ease pain?
Disease control Not yet recruitingThis study tests whether wearing a knee sleeve daily for five years can slow the progression of knee arthritis and reduce pain in adults aged 50 to 64 who have had knee pain for at least three months. Participants are randomly assigned to either wear a knee sleeve every day or no…
Phase: NA • Sponsor: Margaret L Gourlay, MD, MPH • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple attack on lung scarring: could plasma exchange and immune therapy slow IPF?
Disease control Not yet recruitingThis Phase II trial tests whether a combination of therapeutic plasma exchange (filtering the blood), rituximab (a drug that targets certain immune cells), and intravenous immunoglobulin (IVIg) can slow lung decline in people with progressive idiopathic pulmonary fibrosis (IPF). …
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Family-Wide dental treatment may break the cycle of oral infections
Disease control Not yet recruitingThis study investigates how bacteria that cause tooth decay and gum disease spread among family members. Researchers will treat either the child alone, the child and parents, or all family members with professional dental cleaning. They will track bacterial transmission using DNA…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a common acne drug help beat tough fungal infections?
Disease control Not yet recruitingThis study compares the standard antifungal drug itraconazole alone versus itraconazole combined with isotretinoin (an acne medication) in adults with tinea corporis or cruris (ringworm of the body or groin). The goal is to see if the combination shortens treatment time and impro…
Phase: PHASE4 • Sponsor: Pak Emirates Military Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take aim at autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new treatment called C-CAR168 for people with autoimmune diseases like multiple sclerosis, lupus, and myasthenia gravis that have not improved with standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab…
Phase: PHASE1 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Nasal spray ingredient may offer safer dental pulp treatment for kids
Disease control Not yet recruitingThis study tests whether oxymetazoline, a common nasal decongestant, can replace sodium hypochlorite as a bleeding control agent during pulp treatment in children's baby teeth. About 50 Egyptian children aged 4-8 with decayed molars will receive either treatment. The goal is to s…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo aims to tame lupus kidney disease in kids
Disease control Not yet recruitingThis study tests whether combining rituximab with a low dose of mycophenolate mofetil can safely and effectively treat lupus nephritis in children. Lupus nephritis is a serious kidney complication of lupus. The trial enrolls children aged 3 to 18 with active kidney inflammation. …
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
HIV drug repurposed to fight muscle inflammation
Disease control Not yet recruitingThis study tests whether Maraviroc, a drug currently used for HIV, can reduce muscle inflammation and improve function in adults with myositis that hasn't responded to standard treatments. Ten participants will take a daily 300mg tablet for 12 weeks and undergo muscle biopsies an…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple ice water flush prevent pancreatitis after a common procedure?
Disease control Not yet recruitingThis trial investigates whether flushing the bile duct opening with ice-cold water after an ERCP procedure can reduce the chance of developing pancreatitis, a frequent complication. Researchers will compare patients who receive the flush to those who do not, looking at pancreatit…
Phase: NA • Sponsor: Oman Ministry of Health • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take aim at childhood autoimmune diseases
Disease control Not yet recruitingThis early-phase trial tests a single infusion of universal CAR-T cells (RD06-05) in 30 children and adolescents with severe autoimmune diseases, including lupus, scleroderma, and kidney inflammation. The cells are designed to target and calm overactive immune cells. The main goa…
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New injection aims to tame chronic hepatitis b
Disease control Not yet recruitingThis early-stage trial tests an injection called TVAX-028 in adults with chronic hepatitis B. The study checks if the drug is safe and how the body processes it. Participants receive either TVAX-028 with an adjuvant or the adjuvant alone, at different dose levels. The goal is to …
Phase: PHASE1 • Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a drug calm the immune storm in severe abdominal infections?
Disease control Not yet recruitingThis study tests whether ulinastatin, a drug that reduces inflammation, can help patients with severe abdominal infections. The infection often causes the immune system to overreact, leading to organ failure and high risk of death. Researchers will give patients either a low or h…
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Gel boosts gum disease treatment? small study investigates
Disease control Not yet recruitingThis study looks at whether a special gel, called Sterify Gel, can improve the results of standard non-surgical gum disease treatment. Researchers will review records from 20 adults with moderate to severe periodontitis who received deep cleaning plus the gel. The main goal is to…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Head-to-Head: which acne cream works better for clear skin?
Disease control Not yet recruitingThis study compares two topical medications—clascoterone cream and adapalene gel—for treating mild acne vulgaris. Researchers will enroll 60 people aged 12 to 35 with mild acne and randomly assign them to use one of the treatments for 12 weeks. The goal is to see which treatment …
Phase: EARLY_PHASE1 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a daily probiotic boost gum health in smokers?
Disease control Not yet recruitingThis study tests whether adding a daily synbiotic supplement (probiotics plus prebiotic) to standard non-surgical gum treatment improves gum health in smokers with advanced periodontitis. 92 smokers and non-smokers will be split into four groups, receiving either the supplement o…
Phase: NA • Sponsor: Biruni University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New eye drops aim to calm Sjögren's dry eye by blocking inflammation
Disease control Not yet recruitingThis phase 2 trial tests whether eye drops containing infliximab, a drug that blocks a key inflammatory protein, can safely improve severe dry eye in people with Sjögren's syndrome. 38 adults will receive either the active drops or a steroid drop for 6 weeks. The study measures s…
Phase: PHASE2 • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Poop pills for painful skin? fecal transplant trial targets hidradenitis
Disease control Not yet recruitingThis pilot study tests whether fecal microbiota transplantation (FMT) can improve moderate to severe hidradenitis suppurativa (HS), a painful skin condition. Researchers will give 24 adults a single FMT and track changes in their skin lesions over 12 weeks. The goal is to see if …
Phase: PHASE1 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New skin cell transplant combo aims to restore color in white patches
Disease control Not yet recruitingThis study tests two surgical techniques to treat stable white patches on the skin that are not caused by vitiligo. Both methods involve transplanting the patient's own skin cells, followed by laser therapy to boost color return. Twenty-two adults will each receive both treatment…
Phase: NA • Sponsor: Al-Azhar University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Which steroid works best for thick, itchy skin plaques?
Disease control Not yet recruitingThis study compares two standard steroid treatments for hypertrophic lichen planus, a chronic skin condition that causes thick, intensely itchy plaques. Fifty adults will be randomly assigned to apply a strong steroid cream twice daily for 12 weeks or receive steroid injections i…
Phase: PHASE4 • Sponsor: Noor Aziz • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo aims to tame liver side effects of cancer immunotherapy
Disease control Not yet recruitingThis study tests whether combining mycophenolate mofetil (MMF) with prednisone can better treat liver inflammation caused by checkpoint inhibitor cancer drugs. The trial includes adults with moderate to severe immune-related hepatitis who need to pause their cancer therapy. The m…
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a gentler mouthwash win kids over without sacrificing gum health?
Disease control Not yet recruitingThis study tests whether a hyaluronic acid mouthwash is more acceptable to children than a standard chlorhexidine mouthwash, while still controlling plaque-induced gingivitis. Thirty-two children aged 8 to 12 with signs of gingivitis will use one of the two mouthwashes. Researche…
Phase: PHASE1 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New vaginal capsule aims to tackle stubborn bacterial vaginosis
Disease control Not yet recruitingThis study tests a new drug called GenSci142, given as a vaginal capsule, for treating bacterial vaginosis (BV). About 30 women with BV will receive either GenSci142 or a standard antibiotic cream to compare safety and how well each works. The goal is to see if the new capsule is…
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill aims to bring back color to vitiligo skin
Disease control Not yet recruitingThis phase 2a trial tests whether a daily pill called ACT-777991 can help return color to the face of adults with non-segmental vitiligo. About 30 participants will take either the drug or a placebo for 24 weeks. Researchers will measure changes in skin color using a standard sco…
Phase: PHASE2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple inhaled antibiotic stop deadly pneumonia in ventilator patients?
Disease control Not yet recruitingThis study tests whether a 5-day course of inhaled amikacin can prevent ventilator-associated pneumonia in critically ill patients who already have a milder airway infection called tracheobronchitis. 250 adults on breathing machines will receive either the drug or a placebo. The …
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a diabetes drug tame the immune system in kidney disease?
Disease control Not yet recruitingThis phase 2 trial tests whether dapagliflozin, a drug used for diabetes and heart failure, can reduce harmful antibodies and prevent relapses in people with membranous nephropathy, an autoimmune kidney disease. The study enrolls 20 adults who have had a recent rise in anti-PLA2R…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can berries and olives tame inflammation? new study seeks answers
Disease control Not yet recruitingThis pilot study will test whether supplements made from bilberries and olives can reduce inflammation and oxidative stress in people with prediabetes who are overweight. Researchers will collect blood, urine, and stool samples from 60 participants to measure changes in key healt…
Phase: NA • Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New injections aim to melt liver fat in MASH patients
Disease control Not yet recruitingThis clinical trial tests two experimental injections, HRS-4729 and HRS9531, in adults with metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition linked to obesity. The study involves 160 participants who receive either the drug or a placebo for 52 we…
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New trial combines HIV PrEP and STI prevention in one package for young men
Disease control Not yet recruitingThis study tests whether a combined approach—offering HIV PrEP (pills or injections) and STI prevention (doxycycline after sex) along with smartphone tools—helps young men at high risk stay protected. About 400 men aged 18-29 who have sex with men will be followed for a year to s…
Phase: PHASE3 • Sponsor: HIV Prevention Trials Network • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered immune cells take aim at Hard-to-Treat lupus
Disease control Not yet recruitingThis trial tests a one-time treatment called CAR-T cell therapy for people with systemic lupus erythematosus (lupus) that hasn't improved with standard medications. The therapy uses a patient's own immune cells, which are modified in a lab to find and destroy the B cells that dri…
Phase: PHASE1, PHASE2 • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can hip exercises protect knee cartilage in osteoarthritis?
Disease control Not yet recruitingThis trial investigates whether adding hip strengthening exercises to a standard quadriceps program better preserves knee cartilage thickness and improves symptoms in people with knee osteoarthritis. Fifty-six adults with mild-to-moderate knee OA will be randomly assigned to one …
Phase: NA • Sponsor: Pamukkale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drainage procedure could prevent gallbladder attacks without surgery
Disease control Not yet recruitingThis trial tests whether a procedure called EUS-guided gallbladder drainage can prevent future gallbladder attacks in people who are too sick or frail for surgery. Participants are randomly assigned to receive either the drainage procedure or standard medical care. The study will…
Phase: NA • Sponsor: Hospital Mutua de Terrassa • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Dentist's deep clean may delay dialysis for kidney patients
Disease control Not yet recruitingThis study tests whether a deep dental cleaning (subgingival instrumentation) can slow the progression of chronic kidney disease in 40 adults with diabetes and stage IV-V kidney disease. The cleaning aims to reduce inflammation that may worsen kidney function. Researchers will me…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Keyhole vs open surgery for tennis elbow: which offers better pain relief?
Disease control Not yet recruitingThis trial compares two surgical approaches for tennis elbow that has not improved after at least six months of non-surgical treatments like rest or physical therapy. One group receives keyhole (arthroscopic) surgery, while the other receives traditional open surgery. The main go…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Fish oil derivative may calm heart inflammation and stabilize plaques
Disease control Not yet recruitingThis study looks at whether icosapent ethyl, a purified fish oil medication, can reduce inflammation and improve heart structure in people with coronary artery disease. Researchers will follow 420 patients for one year, comparing those who receive standard care plus icosapent eth…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a few weeks of pre-surgery weight training boost hip replacement recovery?
Disease control Not yet recruitingThis study tests whether a supervised resistance exercise program, done for 2 weeks before and 12 weeks after total hip replacement, improves muscle mass and strength in adults aged 60 and older with severe hip osteoarthritis. Participants are randomly assigned to either the exer…
Phase: NA • Sponsor: Universidad de La Frontera • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a common antibiotic ease Kids' bowel disease?
Disease control Not yet recruitingThis study tests whether oral vancomycin, an antibiotic, can help children aged 6-15 with inflammatory bowel disease (IBD), especially types linked to liver problems. About 140 kids will either get vancomycin plus standard care or standard care alone for up to a year. Researchers…
Phase: PHASE2 • Sponsor: Tampere University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Gum disease gel could save your teeth
Disease control Not yet recruitingThis study tests a gel made from doxycycline and atorvastatin in tiny chitosan particles, placed directly into gum pockets after standard deep cleaning. The goal is to reduce gum inflammation, pocket depth, and bone loss in 80 adults with moderate to severe chronic periodontitis.…
Phase: PHASE4 • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Stem cells take on ankylosing spondylitis: first human trial begins
Disease control Not yet recruitingThis early-phase trial is testing whether stem cells from donated bone marrow (CG-BM1) are safe for people with ankylosing spondylitis, a chronic inflammatory arthritis. Forty adults aged 18 to 40 will receive either the stem cells or a placebo by IV once a week for four weeks. T…
Phase: PHASE1 • Sponsor: Eighth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Ancient toothbrush plant tested as a modern pulp saver
Disease control Not yet recruitingThis study tests whether a paste made from Salvadora persica (a plant used in traditional toothbrushes) mixed with zinc oxide can work as well as the standard material (MTA) for treating severe tooth inflammation. The trial involves 78 adults aged 18-40 with infected permanent mo…
Phase: NA • Sponsor: Postgraduate Medical Institute, Lahore • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Two simple calculations could tell cancer from TB in fluid around the lungs
Diagnosis Not yet recruitingThis study looks at whether two simple calculations, called Cancer Ratio and Cancer Ratio Plus, can help doctors tell the difference between fluid around the lungs caused by cancer and fluid caused by tuberculosis. These calculations use results from routine blood and fluid tests…
Sponsor: Sohag University • Aim: Diagnosis
Last updated Aug 18, 2026 02:00 UTC
-
Expired allergy tests: a hidden goldmine or a diagnostic risk?
Diagnosis Not yet recruitingThis study tests whether expired patch test allergens can still accurately diagnose allergic contact dermatitis, a common skin condition. Adults referred for patch testing will receive both expired and non-expired allergens on their skin at the same time. The researchers will com…
Phase: PHASE4 • Sponsor: University of Calgary • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
A simple blood test may reveal kidney damage in lupus — no biopsy needed?
Diagnosis Not yet recruitingThis study asks whether levels of uromodulin, a protein in the blood, can indicate the severity of kidney damage in people with lupus nephritis. Researchers will compare uromodulin levels with kidney biopsy results from 90 participants, including those with different classes of l…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
A simple blood test for lupus kidney damage?
Diagnosis Not yet recruitingThis study investigates whether levels of a protein called RNASE1 in the blood can serve as a biomarker for lupus nephritis, a serious kidney complication of systemic lupus erythematosus (SLE). Researchers will compare RNASE1 levels in 128 adults with SLE, some with lupus nephrit…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
New ultrasound could spot heart danger in cancer patients
Diagnosis Not yet recruitingThis early-phase study tests whether a special ultrasound with a targeted contrast agent (Sonazoid) can quickly diagnose heart inflammation caused by immune checkpoint inhibitor cancer drugs. About 30 adults who recently received these drugs and show signs of heart inflammation w…
Phase: EARLY_PHASE1 • Sponsor: University of Virginia • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
New MRI techniques could sharpen diagnosis of optic nerve inflammation
Diagnosis Not yet recruitingThis study tests whether two advanced MRI techniques, called Double Inversion Recovery (DIR) and Diffusion Tensor Imaging (DTI), can improve the assessment of optic neuritis—inflammation of the optic nerve that can affect vision. Researchers will compare MRI measurements of the a…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Stool test duo could revolutionize cancer surveillance in colitis
Diagnosis Not yet recruitingThis study tests whether combining two stool tests—fecal immunochemical test (FIT) and fecal calprotectin (FC)—can accurately detect precancerous or cancerous changes in people with long-standing ulcerative colitis. Participants will provide stool samples and then undergo a speci…
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Pocket-sized HIV test could bring same-day diagnosis to community clinics
Diagnosis Not yet recruitingThis trial is testing whether the GeneXpert system, a portable device that can run multiple tests, can accurately detect HIV, chlamydia, gonorrhea, hepatitis C, and HPV in community health centers and clinics. Researchers will compare its results to standard lab tests and track w…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
Blood traps may reveal lupus kidney treatment success
Diagnosis Not yet recruitingLupus nephritis is a serious kidney complication of lupus that can lead to kidney failure. This study investigates whether levels of neutrophil extracellular traps (NETs)—web-like structures released by immune cells—in the blood can predict how well patients respond to therapy. R…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Stick-On ultrasound patch could spot liver damage without a specialist
Diagnosis Not yet recruitingThis study tests a new wearable patch-type ultrasound probe that sticks to the skin over the liver to measure stiffness, which can indicate scarring (fibrosis) or cirrhosis. Researchers will compare its accuracy to the standard FibroScan device in 150 adults with chronic liver di…
Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Special formula may help diagnose milk allergy vs intolerance in infants
Diagnosis Not yet recruitingThis study tests whether a partially digested whey formula can help doctors tell the difference between a non-allergic milk intolerance and a true cow's milk protein allergy in babies. Infants aged 1 to 6 months with digestive symptoms will receive the special formula. The goal i…
Phase: NA • Sponsor: Ain Shams University • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New DNA test could sharpen hepatitis b monitoring
Diagnosis Not yet recruitingThis study compares a new, more precise digital PCR test with the standard test for measuring hepatitis B virus levels in people with chronic hepatitis B. Researchers will use leftover blood samples from about 200 patients to see if the new method matches the standard test's accu…
Sponsor: Beijing Municipal Administration of Hospitals • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Ultrasound may solve arthritis diagnosis puzzle
Diagnosis Not yet recruitingRheumatoid arthritis and gout can look alike, making them hard to tell apart early. This study will use ultrasound to see if it can reliably distinguish between the two conditions. Researchers will examine 100 adults with suspected or confirmed arthritis, scoring joint inflammati…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Don't wash that baby! study tests if keeping vernix on prevents eczema
Prevention Not yet recruitingThis study tests whether leaving the white, creamy coating (vernix caseosa) on a newborn's skin for at least 24 hours after birth can prevent eczema (atopic dermatitis) during the first year of life. Over 1,300 mother-infant pairs in Chile will be randomly assigned to either keep…
Phase: NA • Sponsor: Pontificia Universidad Catolica de Chile • Aim: Prevention
Last updated Aug 13, 2026 00:00 UTC
-
Can a simple Self-Test cut preterm births in High-Risk pregnancies?
Prevention Not yet recruitingThis trial tests whether a self-administered vaginal swab, analyzed with advanced molecular technology, can detect and treat bacterial imbalances early in pregnancy. Pregnant women at high risk of preterm birth will either receive this screening plus targeted antibiotics or stand…
Phase: PHASE3 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Probiotic pill aims to stop recurrent cystitis without antibiotics
Prevention Not yet recruitingThis study tests whether a daily probiotic supplement called Colipral® can prevent repeat bladder infections (cystitis) in menopausal women aged 55–70. Participants take either the probiotic or a placebo for 12 weeks and are monitored for 24 weeks to see if they have fewer infect…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Common painkiller may prevent pancreatitis after bile duct procedure
Prevention Not yet recruitingThis trial tests whether a single dose of rectal indomethacin, a common anti-inflammatory drug, can prevent pancreatitis in patients undergoing a bile duct procedure (ERCP) who have had a prior sphincterotomy. About 860 adults will be randomly assigned to receive the drug or no d…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
New pill aims to stop chronic hives fast when antihistamines fail
Symptom relief Not yet recruitingThis early-phase trial tests a new drug called TLL-018 in 36 adults with moderate-to-severe chronic spontaneous urticaria (hives) that standard antihistamines can't control. The goal is to see how quickly TLL-018 reduces itching and hives after the first dose. Participants will r…
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Aug 18, 2026 02:00 UTC
-
Virtual reality could replace pills for pain during ENT procedures
Symptom relief Not yet recruitingThis study compares two types of virtual reality (VR) during common ear, nose, and throat (ENT) procedures. One group will watch calming scenery, while the other plays an interactive puzzle game. Researchers want to see which better reduces pain and anxiety. The study will includ…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Aug 18, 2026 02:00 UTC
-
Can a specialized hand exercise protocol restore grip and ease pain in rheumatoid arthritis?
Symptom relief Not yet recruitingThis trial tests whether a new hand rehabilitation program, called SMART-HAND, can improve hand function, joint position sense, pain, and dexterity in people with rheumatoid arthritis. The program combines sensory training, massage, joint approximation, range-of-motion exercises,…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a textured insole reboot foot sensation and stability?
Symptom relief Not yet recruitingThis study tests whether textured shoe insoles can improve balance, walking, and foot sensation in adults with plantar fasciopathy, a common cause of heel pain. Participants will wear both textured and smooth insoles while researchers measure their postural control, gait, and pla…
Phase: NA • Sponsor: Jennifer Xu • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can retraining the brain unlock a frozen shoulder?
Symptom relief Not yet recruitingThis trial tests whether adding pain neuroscience education and graded motor imagery to standard physiotherapy can improve pain, movement, and fear of movement in people with type 2 diabetes and frozen shoulder. Fifty adults aged 40-65 with diabetic adhesive capsulitis will recei…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
AI videos may ease fear before knee surgery
Symptom relief Not yet recruitingThis study looks at whether using AI-made videos to show patients what happens during knee replacement surgery can lower their anxiety and fear of moving after the operation. About 150 adults aged 55 and older who are scheduled for knee replacement will take part. Half will get s…
Phase: NA • Sponsor: Munzur University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a common steroid speed heart shock recovery?
Symptom relief Not yet recruitingThis study tests if giving a short course of steroids (methylprednisolone) for 7 days can help adults with heart failure who are in cardiogenic shock, a serious condition where the heart can't pump enough blood. The goal is to reduce harmful inflammation and help patients recover…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Learning to Self-Care: a new approach to ease RA stiffness?
Symptom relief Not yet recruitingThis trial tests whether a structured self-care education program can reduce joint stiffness and improve functional ability in people with rheumatoid arthritis. Participants are split into two groups: one receives the education program alongside usual care, while the other gets u…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New eye drop aims to soothe dryness after cataract surgery
Symptom relief Not yet recruitingThis pilot study tests a new preservative-free eye drop called NOX-01 in people with mild to moderate dry eye who are having cataract surgery. The drop is designed to lubricate and protect the eye surface, potentially reducing the dry eye symptoms that often occur after surgery. …
Phase: NA • Sponsor: NOXELIS • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Bone marrow injection may offer longer hip pain relief than steroids
Symptom relief Not yet recruitingThis study tests whether a single injection of concentrated bone marrow cells can reduce pain and improve function in people with hip osteoarthritis better than a standard steroid injection. One hundred adults with moderate to severe hip arthritis will be randomly assigned to rec…
Phase: PHASE3 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a pain drug help you walk better with knee arthritis?
Symptom relief Not yet recruitingThis trial tests whether duloxetine, an FDA-approved osteoarthritis drug, can improve walking ability and physical activity in people with chronic knee osteoarthritis pain. Participants take duloxetine or a placebo for six weeks, then complete surveys, physical tasks, brain imagi…
Phase: PHASE4 • Sponsor: Benedict Alter • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Herbal drops aim to melt away sore throat pain
Symptom relief Not yet recruitingThis trial tests whether Yanlishuang buccal dropping pills, a traditional Miao medicine, can relieve the sore throat and pain of acute pharyngitis. About 400 adults with a sore throat that started within the last 48 hours will be randomly assigned to take either the herbal drops …
Phase: NA • Sponsor: Beijing University of Chinese Medicine • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could a bedtime supplement ease Post-Workout soreness?
Symptom relief Not yet recruitingThis trial tests whether a magnesium-based supplement taken before bed can improve sleep quality and speed up recovery after intense exercise. Healthy, recreationally active adults aged 18-40 will take the supplement or a placebo for two weeks each, then complete a leg exercise p…
Phase: NA • Sponsor: University of Exeter • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can a laser beam replace opioids for knee surgery pain?
Symptom relief Not yet recruitingThis pilot study tests whether photobiomodulation therapy—using a special laser device—can reduce pain in people who go home the same day as their total knee replacement surgery. Participants receive the light therapy as part of their post-operative pain plan, and their pain leve…
Phase: NA • Sponsor: Mohammad Burney, MD • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Could a bent knee after surgery speed up recovery?
Symptom relief Not yet recruitingThis trial asks whether keeping the knee slightly bent for a few hours after knee replacement surgery improves recovery compared to the usual straight position. About 150 adults scheduled for a knee replacement will be randomly assigned to either have their knee positioned at a 6…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a VR headset ease pancreatitis pain?
Symptom relief Not yet recruitingThis study tests whether using a virtual reality headset at home can help adults with chronic pancreatitis manage their pain. Twenty participants will use either a gut-directed VR therapy or a distraction-based VR for 8 weeks. The main goal is to see if people can stick with the …
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a sedative calm the Body's surgical storm?
Symptom relief Not yet recruitingThis trial tests whether giving the sedative dexmedetomidine during hip replacement surgery can dampen the body's stress and inflammatory response to the operation. Researchers will compare two doses of the drug against a placebo in 90 adults aged 50-90 undergoing total hip arthr…
Phase: NA • Sponsor: Poznan University of Medical Sciences • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can blocking knee blood vessels ease arthritis pain?
Symptom relief Not yet recruitingThis trial tests whether a procedure called genicular artery embolization can reduce pain and improve function in people with knee osteoarthritis who have not responded to standard treatments. Doctors insert a thin tube into an artery in the groin, guide it to blood vessels aroun…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Bee venom zaps sinus pain? new trial tests sting therapy
Symptom relief Not yet recruitingThis study tests whether applying bee venom to the face using ultrasound can ease chronic sinusitis symptoms. Thirty adults with sinusitis will either get bee venom phonophoresis or standard care (decongestants and saline rinses). Researchers will measure changes in symptom sever…
Phase: NA • Sponsor: Sinai University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Bee venom gel could soothe arthritic knees, small trial hopes
Symptom relief Not yet recruitingThis study tests whether applying bee venom gel to the knee during ultrasound therapy can reduce pain and improve movement in people with knee osteoarthritis. Thirty adults aged 40-75 will either get the bee venom treatment or a placebo gel. Researchers will measure pain, walking…
Phase: NA • Sponsor: Sinai University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Needle in hand, heel pain gone? new study investigates
Symptom relief Not yet recruitingThis study tests if a specific acupuncture point on the hand can safely reduce heel pain and improve walking. Researchers will treat 150 adults aged 40-70 who have had heel pain for less than two months. The main goal is to see if at least half of participants get significant pai…
Phase: NA • Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Which nerve block keeps you moving after knee surgery?
Symptom relief Not yet recruitingThis trial compares two ultrasound-guided nerve blocks for pain control after total knee replacement. The goal is to see if one block preserves leg muscle strength better, allowing earlier movement, while providing similar pain relief. Sixty adults scheduled for knee replacement …
Phase: NA • Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Could a simple pill make root canals less painful?
Symptom relief Not yet recruitingThis trial tests whether taking a single dose of diclofenac potassium before dental treatment can improve the numbing effect of local anesthesia and reduce pain after the procedure. Adults with severe tooth pain from irreversible pulpitis in lower molars will receive either 50mg,…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
One shot, one year: could a single injection ease knee arthritis pain?
Symptom relief Not yet recruitingThis phase 3 trial tests whether a single injection of hyaluronic acid into the knee can reduce pain and improve function in people with moderate knee osteoarthritis over 12 months. The study includes adults aged 40 to 75 who have persistent knee pain despite standard treatments …
Phase: PHASE3 • Sponsor: Universiti Sains Malaysia • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Art as medicine: can drawing and painting help sick kids feel better about themselves?
Symptom relief Not yet recruitingThis trial tests whether a structured art therapy program, grounded in positive psychology, can improve self-compassion and hope in children aged 8 to 12 who are staying in a hospital ward. Half of the 80 participants will receive the art therapy sessions alongside standard nursi…
Phase: NA • Sponsor: Suleyman Demirel University • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Hormone therapy may thaw frozen shoulders faster — a trial puts it to the test
Symptom relief Not yet recruitingThis trial tests whether adding hormone replacement therapy (HRT) to a standard physiotherapy program improves pain, movement, and function in postmenopausal women with frozen shoulder. Fifty-six women aged 40 to 60 with stage I or II frozen shoulder will receive 12 weeks of supe…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Can a thicker gel ease shoulder pain better?
Symptom relief Not yet recruitingThis trial tests whether an ultra-high molecular weight hyaluronic acid injection works better than a standard high molecular weight version for subdeltoid bursitis, a painful shoulder condition. About 50 adults with recent shoulder pain will receive an ultrasound-guided injectio…
Phase: PHASE4 • Sponsor: Shin Kong Wu Ho-Su Memorial Hospital • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Acne fighters: ubiquinol and pomegranate peel extract put to the test
Symptom relief Not yet recruitingThis 28-day study is testing whether a lotion containing ubiquinol, pomegranate peel extract, ceramides, and salicylic acid can improve acne lesions and skin comfort in adults with mild-to-moderate acne. Forty participants aged 18 to 40 will use the lotion daily alongside their u…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Chilling a tooth from the inside: could cold saline ease Post-Root-Canal pain?
Symptom relief Not yet recruitingThis trial tests whether flushing the inside of a tooth with cold saline (about 2.5°C) after root canal retreatment can lower pain and inflammation. One hundred adults needing retreatment on a lower premolar will be randomly assigned to receive either cold or room-temperature sal…
Phase: NA • Sponsor: Alanya Alaaddin Keykubat University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a gel injection ease shoulder bursitis pain?
Symptom relief Not yet recruitingThis trial tests whether injecting hyaluronic acid into the shoulder, combined with physical therapy, can reduce pain and disability from subdeltoid bursitis. Fifty participants receive either cross-linked or non-cross-linked hyaluronic acid, guided by ultrasound. Researchers tra…
Phase: NA • Sponsor: Shin Kong Wu Ho-Su Memorial Hospital • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Weight-loss drug ecnoglutide takes aim at knee osteoarthritis pain
Symptom relief Not yet recruitingThis phase 3 trial tests whether ecnoglutide, a GLP-1 drug similar to semaglutide, can reduce knee pain and body weight in obese adults with knee osteoarthritis. Participants receive either ecnoglutide injections or a placebo for several months. The study measures changes in pain…
Phase: PHASE3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
A digital coach for knee replacement recovery — can it boost satisfaction and exercise?
Symptom relief Not yet recruitingThis pilot trial tests whether a web-based conversational assistant can help people recovering from total knee replacement. About 60 adults who have had knee replacement surgery will either receive standard care alone or standard care plus access to the online assistant for 6 wee…
Phase: NA • Sponsor: Wojciech Sroga • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Less pressure, less pain? trial tests gentler gas levels for appendix surgery
Symptom relief Not yet recruitingThis trial compares two standard gas pressures used during laparoscopic appendectomy — 10 mmHg versus 15 mmHg — to see which leads to less pain and faster recovery. About 150 adults with uncomplicated appendicitis will be randomly assigned to one pressure level. Researchers will …
Phase: NA • Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Ice vs spray: which stops chemo mouth pain?
Symptom relief Not yet recruitingThis trial compares two simple treatments—sucking on ice chips or using a lidocaine spray—to see which better prevents or reduces painful mouth sores caused by chemotherapy. About 60 adults with cancer who are about to receive chemotherapy will be randomly assigned to one of the …
Phase: NA • Sponsor: Hanady Jabbar Mahmood • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a specific mobilization technique unfreeze a frozen shoulder faster?
Symptom relief Not yet recruitingThis trial compares two hands-on therapy techniques—Gong's mobilization and Maitland mobilization—for treating adhesive capsulitis, commonly known as frozen shoulder. The study includes adults aged 40 to 65 with moderate pain and limited shoulder movement. Researchers are measuri…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
A gentle pull: could manual traction speed up knee replacement recovery?
Symptom relief Not yet recruitingThis trial tests whether adding a hands-on technique called manual traction to standard physical therapy can reduce pain and improve function in women recovering from total knee replacement. Forty-eight women aged 50 to 75 with knee osteoarthritis will be randomly assigned to rec…
Phase: NA • Sponsor: Alma Mater Europaea - Slovenia • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Could a special screen light reduce tired eyes and dryness?
Symptom relief Not yet recruitingThis study tests whether a full-spectrum screen bar light can reduce eye fatigue and dry eye symptoms after two hours of computer work. Healthy adults aged 18 to 35 who use screens at least four hours daily will be randomly assigned to use the light or a standard screen without i…
Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Can a gentler root canal tool ease post-treatment pain?
Symptom relief Not yet recruitingThis trial compares two different file systems used during root canal treatment for infected lower molars. The goal is to see whether a newer, minimally invasive single-file system leads to less pain after the procedure than the standard Wave One Gold system. Adults with a specif…
Phase: NA • Sponsor: Minia University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Could a back injection ease the need for life support in pancreatitis?
Symptom relief Not yet recruitingThis study tests whether a thoracic epidural block—a numbing injection near the spine—can help people with severe acute pancreatitis avoid or shorten the need for intensive care support like breathing machines and kidney dialysis. Participants are randomly assigned to receive eit…
Phase: NA • Sponsor: First People's Hospital of Chenzhou • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Custom 3D-Printed stents could spare kids with brain cancer from painful mouth sores
Symptom relief Not yet recruitingThis trial tests whether custom 3D-printed intraoral stents can protect the mouth from radiation damage in children with medulloblastoma, a type of brain cancer. During radiotherapy, the stent is worn inside the mouth to physically move healthy tissue away from the radiation beam…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Could the way a dentist moves a tiny file ease root canal pain?
Symptom relief Not yet recruitingThis trial looks at whether changing how the dentist's tool moves during a root canal can reduce pain afterward. Adults with an infected lower premolar will get standard root canal treatment, but the file system will use either a continuous spin or a back-and-forth motion, with d…
Phase: NA • Sponsor: Alanya Alaaddin Keykubat University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New allergy pill could offer relief from sneezing and stuffy nose
Symptom relief Not yet recruitingThis study tests an experimental antihistamine called rupatifen fumarate for people with seasonal allergic rhinitis (hay fever). About 550 adults aged 18 to 65 with at least a 2-year history of seasonal allergies will take either the new drug, an existing antihistamine, or a plac…
Phase: PHASE3 • Sponsor: Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Breathing against resistance may ease knee arthritis pain
Symptom relief Not yet recruitingThis study tests whether a simple breathing exercise—inhaling against resistance using a handheld device—can reduce knee pain in people aged 55 and older with knee osteoarthritis. Participants will do the exercises at home for 8 weeks, with gradually increasing resistance. The tr…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could a squeeze of acid make gum Dark-Spot removal look better?
Symptom relief Not yet recruitingThis study tests whether applying citric acid during a procedure to remove dark gum pigmentation leads to better-looking results and faster healing. Adults aged 18 to 50 with natural dark gums will receive either standard depigmentation or depigmentation plus acid. The researcher…
Phase: NA • Sponsor: Dijlah University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could a simple spray shield cancer patients from radiation burns?
Symptom relief Not yet recruitingThis trial tests whether a spray containing superoxide dismutase, an antioxidant enzyme, can reduce severe skin reactions caused by radiation therapy. Head and neck cancer patients scheduled for radiotherapy apply the spray five times daily to the treated skin area. The study com…
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Virtual reality could replace sedatives for anxious hip surgery patients
Symptom relief Not yet recruitingThis study tests whether using a virtual reality (VR) headset during hip replacement surgery can lower anxiety and prevent post-surgery confusion in older adults. Half of the participants will watch calming nature scenes through VR while under regional anesthesia, while the other…
Phase: NA • Sponsor: Menoufia University • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Could a single injection after knee surgery cut swelling in half?
Symptom relief Not yet recruitingThis trial tests whether an injection of tergase (berahyaluronidase alfa) can reduce swelling after total knee replacement surgery. The study involves 30 older adults with severe knee osteoarthritis who are having both knees replaced at the same time. One knee receives the inject…
Phase: NA • Sponsor: Man Soo Kim • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New biologic aims to quiet the itch of a chronic skin condition
Symptom relief Not yet recruitingThis phase 2 trial tests whether nemolizumab, an injectable biologic, can reduce severe itching in women with vulvar lichen sclerosus, a chronic inflammatory skin condition. Participants receive weight-based doses of the drug and track their itch scores daily. The study focuses o…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Simple foot exercises may offer Drug-Free relief for chronic heel pain
Symptom relief Not yet recruitingThis study compares two non-surgical approaches—foot core strengthening and sensorimotor re-training—each added to routine physical therapy, for treating plantar fasciitis. Adults aged 35–60 with at least three months of heel pain are randomly assigned to one of the two groups. R…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could a simple saltwater rinse revolutionize Post-Root canal pain relief?
Symptom relief Not yet recruitingThis study tests whether a 3% hypertonic saline (saltwater) rinse, used at the end of a root canal procedure, can reduce pain and inflammation better than the standard 0.9% saline rinse. Forty adults with painful tooth inflammation will receive one of the two rinses, and their pa…
Phase: PHASE4 • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could a single injection ease vaginal dryness? new trial tests hyaluronic acid gel
Symptom relief Not yet recruitingThis trial tests F-GYN, a single-use injectable gel made of non-crosslinked hyaluronic acid, for women with moderate to severe vaginal dryness and atrophy. Participants either receive the injection right away or continue standard non-hormonal care for 4 weeks before getting the i…
Phase: NA • Sponsor: Biovico Sp. z o.o. • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Laser vs radiofrequency: a new hope for knee pain relief?
Symptom relief Not yet recruitingThis trial tests whether using a laser to ablate (destroy) specific nerves around the knee provides better pain relief than the standard radiofrequency method for people with chronic knee osteoarthritis. Fifty adults with persistent knee pain will receive one of the two procedure…
Phase: NA • Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could an antidepressant ease chronic bladder pain? new trial investigates
Symptom relief Not yet recruitingThis trial compares two approaches for adults with interstitial cystitis, a condition causing long-term bladder pain and frequent urination. All participants receive education and behavioral training, while half also take the antidepressant venlafaxine for 12 weeks. Researchers w…
Phase: PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Could a simple steroid shot make root canals less painful?
Symptom relief Not yet recruitingThis trial investigates whether a single injection of dexamethasone, a steroid, given before a root canal can lower pain during the procedure. It includes adults with severe tooth pain from symptomatic irreversible pulpitis. Participants receive either dexamethasone or a placebo,…
Phase: PHASE4 • Sponsor: Watim Medical & Dental College • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Ancient herbal formula may soothe radiation burns in the mouth
Symptom relief Not yet recruitingThis study tests whether a traditional Chinese herbal drink called Sancai Fengsui Decoction can help heal painful mouth sores caused by radiation therapy for head and neck cancer. About 126 adults who have developed moderate to severe mouth sores after radiation will receive eith…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New cream with plant extract aims to heal Incontinence-Related skin damage
Symptom relief Not yet recruitingThis study tests a new barrier cream (Dermategrity "Anti-fecal" Barrier Cream) that contains zinc oxide and a natural plant extract to protect and heal skin damaged by incontinence. Sixty adults with incontinence-associated dermatitis will receive either the new cream or a standa…
Phase: NA • Sponsor: Scotiaderm • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could a common painkiller speed up cellulitis recovery?
Symptom relief Not yet recruitingCellulitis is a painful bacterial skin infection. This study tests whether adding naproxen (an anti-inflammatory drug) to standard antibiotics helps reduce redness and pain faster than antibiotics alone. About 884 adults with cellulitis will take either naproxen or a placebo for …
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Simple leg exercise may cut swelling and pain after knee replacement
Symptom relief Not yet recruitingThis study tests whether adding a simple leg exercise to standard recovery care can reduce swelling and inflammation after total knee replacement. The exercise involves lying or sitting while lifting the leg and moving the ankle. Researchers will measure leg swelling and pain in …
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New pill aims to quiet chronic hives without the itch
Symptom relief Not yet recruitingThis early-stage trial tests an experimental tablet called Alpha-0261 in people with chronic spontaneous urticaria (long-lasting hives) and in healthy volunteers. The study checks the drug's safety, how the body processes it, and whether it reduces hive activity and itching. Part…
Phase: PHASE1 • Sponsor: AlphaMol Science Ltd. (Shanghai) • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New nerve block could match standard for hip replacement pain
Symptom relief Not yet recruitingThis trial compares two types of nerve blocks given before hip replacement surgery to control pain afterward. One is the standard supra-inguinal fascia iliaca compartment block (SI-FICB), and the other is a newer quadro-iliac plane block (QIPB). The study includes adults aged 18-…
Phase: NA • Sponsor: Dokuz Eylul University • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Shockwave therapy may ease stubborn achilles pain
Symptom relief Not yet recruitingThis study tests whether adding shockwave therapy to a tailored exercise program reduces pain and improves function in people with Achilles tendon pain. Two hundred adults with pain in the mid-portion or insertion of the tendon will be randomly assigned to exercise alone or exerc…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New knee pain treatment approach tested in pilot study
Symptom relief Not yet recruitingThis pilot study compares two standard-of-care radiofrequency ablation (RFA) techniques for chronic knee pain caused by osteoarthritis. Adults already scheduled for knee RFA are randomly assigned to receive either a standard 3-target or a novel 6-target nerve ablation protocol. T…
Phase: NA • Sponsor: Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Could a simple supplement boost knee injection results for arthritis sufferers?
Symptom relief Not yet recruitingThis study tests whether adding an oral supplement (PEA) to a series of knee injections (adelmidrol and hyaluronic acid) can better reduce pain and improve function in people with knee arthritis. The injections aim to protect the joint from damage, while the supplement may help c…
Phase: NA • Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New eye drop aims to soothe dry eyes from too much screen time
Symptom relief Not yet recruitingThis study compares a new eye drop (perfluorohexyloctane) with a standard one (sodium hyaluronate) for people whose eyes get dry from using screens for more than 6 hours a day. Participants aged 18 to 70 with mild to moderate dry eye will use the drops four times daily for 8 week…
Phase: PHASE4 • Sponsor: Beijing Tongren Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New injection could tame teen hay fever
Symptom relief Not yet recruitingThis study tests whether an injection called stapokibart can reduce nasal allergy symptoms like runny nose, congestion, sneezing, and itching in adolescents aged 12 to 17 with seasonal allergic rhinitis (hay fever). Participants receive either stapokibart or a placebo alongside t…
Phase: PHASE3 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New study aims to cut opioid use after knee replacement with targeted nerve blocks
Symptom relief Not yet recruitingThis trial compares three ways to manage pain after total knee replacement. All patients receive standard nerve blocks, but some also get an anti-inflammatory drug (dexamethasone) or a combination of dexamethasone and a sedative (dexmedetomidine). The goal is to see which approac…
Phase: NA • Sponsor: Poznan University of Medical Sciences • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a cold rinse during root canals ease Post-Procedure pain?
Symptom relief Not yet recruitingThis study tests whether using very cold water (around 2-3°C) to rinse the inside of a tooth during a root canal can lower pain afterward. The trial includes adults aged 20-40 with painful, infected lower molars. Participants are randomly assigned to receive either cold rinses th…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Laser light could ease knee arthritis without drugs or surgery
Symptom relief Not yet recruitingThis study investigates whether adding High-Intensity Laser Therapy (HILT) to standard physiotherapy helps people with mild-to-moderate knee osteoarthritis. Seventy-two participants will receive either real or sham laser sessions alongside exercise-based physiotherapy. Researcher…
Phase: NA • Sponsor: University of Rzeszow • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can a 2-Hour online class ease IBD pain?
Symptom relief Not yet recruitingThis study tests two online pain education programs for adults with Crohn's disease or ulcerative colitis who have chronic pain. Participants will complete a 2-hour online session and report their pain and quality of life weekly for 8 weeks. The goal is to see if these programs a…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a phone app help RA patients feel less anxious?
Symptom relief Not yet recruitingThis study tests whether an 8-week program of yoga and meditation delivered through a mobile app can reduce anxiety in adults with stable rheumatoid arthritis. About 100 participants will either use the app daily or continue with standard care. Researchers will measure changes in…
Phase: NA • Sponsor: Tugba Civi Karaaslan • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Chill after the drill: could cold saline soothe root canal pain?
Symptom relief Not yet recruitingThis study looks at whether using a cold saline rinse after ultrasonic cleaning during a root canal can lower pain afterward. Adults with an inflamed tooth nerve will get either ultrasonic cleaning alone or followed by a cold saline flush. Pain levels are tracked for three days a…
Phase: NA • Sponsor: Dr Arsalan Ali Khan • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Laser vs. electric patch: which eases knee pain best?
Symptom relief Not yet recruitingThis study will compare two treatments—low-level laser therapy and iontophoresis (a method that uses a mild electric current to deliver medication through the skin)—for knee osteoarthritis. Sixty-six adults aged 45 to 65 with mild to moderate knee arthritis will be randomly assig…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a common muscle relaxant cut narcotic use after hysterectomy?
Symptom relief Not yet recruitingThis study tests whether adding cyclobenzaprine, a muscle relaxant, to standard pain medicines (ibuprofen, acetaminophen, and short-term narcotics) improves pain control and reduces narcotic use after minimally invasive hysterectomy. About 36 women undergoing laparoscopic hystere…
Phase: PHASE4 • Sponsor: Christiana Care Health Services • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Which probiotic stops Kids' diarrhea faster? new trial aims to find out
Symptom relief Not yet recruitingThis study will compare two probiotic drinks—Bacillus clausii and a mix of four bacterial strains—in 138 children aged 1 to 5 with acute watery diarrhea. All children will also receive standard care like rehydration and zinc. The goal is to see which probiotic reduces diarrhea du…
Phase: NA • Sponsor: Children Hospital and Institute of Child Health, Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Bladder gel shots aim to ease chronic pelvic pain
Symptom relief Not yet recruitingThis pilot study tests whether injecting hyaluronic acid directly into the bladder wall is safe and can reduce pain and frequent urination in people with interstitial cystitis (bladder pain syndrome). Fifteen adults who haven't improved after standard treatments will receive the …
Phase: PHASE1 • Sponsor: Sverdlovsk Regional Clinical Hospital No.1 • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New eye drop aims to soothe dry eyes Long-Term
Symptom relief Not yet recruitingThis study tests whether acoltremon eye drops can improve symptoms and tear production in people with dry eye disease over 12 months. Sixty adults will be randomly assigned to receive either the active drug or a standard artificial tear. Researchers will track changes in eye disc…
Sponsor: The Eye Care Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Zoom yoga for young arthritis patients: a new hope?
Symptom relief Not yet recruitingThis study will test whether an 8-week yoga program done live over Zoom can improve balance, endurance, and well-being in 32 children aged 8-12 with juvenile idiopathic arthritis (JIA). The yoga sessions are led by certified physiotherapists and include breathing, poses, and medi…
Phase: NA • Sponsor: Akdeniz University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Heel pain breakthrough? new study pits needle therapy against surgery
Symptom relief Not yet recruitingThis study compares a 6-week non-surgical treatment (manual therapy plus nerve stimulation) with surgery for people who have had heel pain for over 6 months and haven't gotten better with standard care. 120 adults aged 30-65 will choose their preferred treatment and be followed f…
Phase: NA • Sponsor: Universidad Europea de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a smartphone app ease the Gut-Brain struggle for IBD patients?
Symptom relief Not yet recruitingThis study tests a mobile app designed to help Black and Hispanic adults with inflammatory bowel disease (IBD) manage stress and improve their quality of life. The app teaches coping skills, mindfulness, and disease acceptance. Researchers want to see if the app is practical and …
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Shockwave or laser: the battle to end tennis elbow pain
Symptom relief Not yet recruitingThis study compares two non-surgical treatments—shockwave therapy and high-power laser—for chronic tennis elbow (lateral epicondylitis) that has lasted over 3 months. Seventy-two adults aged 40-50 will receive one of the treatments plus standard physical therapy. Researchers will…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study tests nerve stretching to ease heel pain
Symptom relief Not yet recruitingThis study will compare two types of nerve mobilization added to standard physical therapy for chronic plantar fasciitis. Sixty adults with heel pain for at least six weeks will be randomly assigned to receive either posterior tibial nerve mobilization or saphenous nerve mobiliza…
Phase: NA • Sponsor: Prince Sattam Bin Abdulaziz University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a daily yogurt soothe your gallbladder?
Symptom relief Not yet recruitingThis study tests whether a special yogurt containing the probiotic Pediococcus acidilactici GR-5 can help people with chronic cholecystitis (long-term gallbladder inflammation). Fifty adults with the condition will eat either the probiotic yogurt or a regular placebo yogurt daily…
Phase: NA • Sponsor: LanZhou University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a pill plus walking ease knee pain and lift mood in veterans?
Symptom relief Not yet recruitingThis study tests whether combining the medication duloxetine with a structured walking program can improve physical function, reduce pain, and ease depressive symptoms in veterans with knee osteoarthritis. Participants will be assigned to either the drug-plus-exercise group or a …
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
AI coach may soothe radiation skin burns in breast cancer patients
Symptom relief Not yet recruitingThis study tests whether an artificial intelligence-powered digital education program can reduce the severity of radiodermatitis (skin irritation from radiation) and improve quality of life in women with breast cancer. 38 patients will be randomly assigned to either receive the A…
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Walking backwards could be a simple way to ease knee arthritis pain
Symptom relief Not yet recruitingThis study tests whether walking backwards on a treadmill (called retro walking) can help reduce pain and improve how people with knee osteoarthritis walk. Participants will do retro walking sessions, starting with 10 minutes and gradually increasing up to 30 minutes if pain stay…
Phase: NA • Sponsor: Anglia Ruskin University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New exercise program aims to ease knee pain in seniors
Symptom relief Not yet recruitingThis study tests a physical therapy program designed for older adults with knee osteoarthritis. The program focuses on mobility, balance, and fall prevention, and also considers each person's mental abilities. Forty participants aged 60 and older will take part in 16 sessions ove…
Phase: NA • Sponsor: King Saud University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can we predict who survives meningitis? a new study seeks answers
Knowledge-focused Not yet recruitingThis study looks at the medical records of 300 people treated for meningitis at a hospital in Sohag, Egypt, to understand what factors influence their chances of recovery. Researchers will review past cases and follow new patients for a year, tracking who survives, who recovers f…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Scientists launch deep dive into IBD to uncover hidden clues
Knowledge-focused Not yet recruitingThis study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to fi…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Can a vacuum device safely suck out dangerous heart clots? a global registry investigates
Knowledge-focused Not yet recruitingThis study is a large international registry that will look back at the medical records of about 1,000 adults who were treated with the AngioVac system, a device that uses suction to remove blood clots, infected tissue, or other unwanted material from the heart and major blood ve…
Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Can a new eye scanner match the gold standard?
Knowledge-focused Not yet recruitingThis study evaluates whether an investigational eye imaging device, UNITY DX, can measure the thickness of the cornea and its epithelial layer as accurately and consistently as a commercially available device. About 110 participants with normal or abnormal corneas will undergo mu…
Sponsor: Alcon Research • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Can a new turkish questionnaire measure menstrual knowledge in athletes?
Knowledge-focused Not yet recruitingThis study aims to adapt the Menstrual Cycle Knowledge Questionnaire (MCKQ) into Turkish and check whether it is a valid and reliable tool for female athletes. Researchers will ask 120 women aged 16 to 35 who are licensed athletes to fill out the questionnaire, along with other s…
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Could a simple scan and blood test outsmart liver cancer?
Knowledge-focused Not yet recruitingThis study looks at whether a structured surveillance program using regular ultrasound and a blood test (alpha-fetoprotein) can detect liver cancer at an earlier, more treatable stage in people at high risk. About 300 adults with liver cirrhosis, chronic hepatitis B, or advanced …
Sponsor: D'Or Institute for Research and Education • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Could a simple X-Ray measurement outperform BMI in knee surgery safety?
Knowledge-focused Not yet recruitingThis study investigates whether the thickness of fat over the shin bone, measured on a standard knee X-ray, is a better predictor of infection after total knee replacement than Body Mass Index (BMI). Researchers will review data from 400 adults who had knee replacement surgery, c…
Sponsor: East Lancashire Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Blood and gut clues may flag pancreatic cancer risk early
Knowledge-focused Not yet recruitingThis observational study is investigating whether certain blood markers and gut microorganisms can help identify people with chronic pancreatitis who are at higher risk of developing pancreatic cancer. Researchers will compare healthy individuals, those with chronic pancreatitis,…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can Weight-Loss surgery rewire the Liver's energy engine?
Knowledge-focused Not yet recruitingThis study looks at how bariatric surgery affects the liver's energy processing in people with obesity and fatty liver disease. Researchers will use safe, non-radioactive tracer infusions and MRI scans before, during, and six months after surgery to measure changes in liver metab…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Immune clues in the blood may foretell heart trouble
Knowledge-focused Not yet recruitingThis study is building a biobank of blood samples and imaging data from 300 people with suspected inflammatory heart or autoimmune rheumatic diseases. Researchers aim to identify immune biomarkers that could predict major heart events like heart failure, stroke, or atrial fibrill…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can we predict acute pancreatitis outcomes?
Knowledge-focused Not yet recruitingThis study looks at adults with acute pancreatitis, a sudden inflammation of the pancreas, to understand the different ways it presents and what happens to patients. Researchers will track 100 participants to identify patterns and potential predictors of outcomes. The goal is to …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Could a simple protein test unlock the secrets of joint disease?
Knowledge-focused Not yet recruitingThis study looks at whether levels of a protein called 15-PGDH in the blood and joint fluid are linked to the severity of osteoarthritis and ankylosing spondylitis. Researchers will measure 15-PGDH in about 51 adults with these conditions and compare it with ultrasound images and…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Gum bacteria and a 'Youth Gene' may hold clues to heart attack risk
Knowledge-focused Not yet recruitingThis study will examine 108 adults aged 30-65 to see if a gene called Klotho, certain mouth bacteria, and viruses are linked to gum disease and acute coronary syndrome (a type of heart attack). Researchers will measure gum health and collect samples to look for these markers. The…
Sponsor: Meenakshi Ammal Dental College and Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can your phone's camera measure psoriasis redness as well as a doctor?
Knowledge-focused Not yet recruitingThis study aims to develop and test an AI system that uses smartphone photos with a color card to measure redness in psoriasis lesions. Fifty adults with psoriasis will take weekly photos at home and have clinic photos taken. The goal is to see if this simple, low-cost method mat…
Sponsor: Khon Kaen University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
AI vs. human: which doctor video boosts psoriasis treatment adherence?
Knowledge-focused Not yet recruitingThis study explores whether short, AI-generated videos from a virtual doctor can help people with psoriasis stick to their topical medication routine. Fifteen adults will be split into three groups: weekly AI videos, weekly human doctor videos, or standard care (one follow-up vis…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Can a prefilled pen match a syringe for this biosimilar?
Knowledge-focused Not yet recruitingThis study compares two ways of giving the same experimental biosimilar drug, DRL_AB, which is designed to work like abatacept for autoimmune conditions. Healthy male volunteers receive a single dose either through an autoinjector or a prefilled syringe. Researchers measure how m…
Phase: PHASE1 • Sponsor: Dr. Reddy's Laboratories Limited • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Knee implant materials put to the test in human cells
Knowledge-focused Not yet recruitingThis study will test whether common orthopedic materials, like titanium alloy and polylactic acid (PLA), are safe for use in knee surgery. Researchers will expose human tissue samples from 50 knee replacement patients to these materials in the lab. They will check for cell damage…
Sponsor: Stefano Zaffagnini • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Blood, urine, and stool may hold the key to predicting a serious side effect of lung cancer treatment
Knowledge-focused Not yet recruitingThis study is looking at whether analyzing blood, urine, and stool samples can help predict which lung cancer patients are more likely to develop radiation pneumonitis—a type of lung inflammation—after receiving immunotherapy and radiation therapy. The researchers will collect sa…
Sponsor: HAN GUANG • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Could a single meningitis shot protect for years? a study investigates
Knowledge-focused Not yet recruitingThis study follows 180 children who received a meningitis vaccine (ACYW135 conjugate) years ago to see if their immune protection lasts. Researchers will measure antibody levels in blood samples taken 3 and 5 years after vaccination. The goal is to understand how long immunity pe…
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Rewiring the immune system: a new hope for children with severe IBD?
Knowledge-focused Not yet recruitingThis study investigates why children with inflammatory bowel disease (IBD) have an overactive immune response in the gut, and whether blood stem cells can be engineered to restore tolerance. Researchers will analyze blood and intestinal tissue samples from 80 children with IBD, w…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
New study to measure drug levels in breast milk of moms on TREMFYA
Knowledge-focused Not yet recruitingThis study will measure how much of the drug TREMFYA (guselkumab) passes into breast milk of 10 nursing women who are already taking it for conditions like psoriasis, psoriatic arthritis, ulcerative colitis, or Crohn's disease. Researchers will collect milk samples to estimate th…
Phase: PHASE4 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Olive oil and xylitol mouth rinse may shield cancer patients from painful mouth sores
Knowledge-focused Not yet recruitingThis study looks back at the medical records of 60 adults with head and neck cancer who received radiation therapy, with or without chemotherapy, and used a topical mouth rinse made from olive oil, betaine, and xylitol. The goal is to see how often severe mouth sores (oral mucosi…
Sponsor: Mucosa Innovations, S.L. • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Can a brain monitor guide safer anesthesia during knee replacement?
Knowledge-focused Not yet recruitingThis trial tests whether adding midazolam, dexmedetomidine, or esketamine to standard propofol anesthesia helps maintain the right depth of unconsciousness during knee replacement. One hundred adults scheduled for surgery will have their brain waves and vital signs monitored as t…
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Can a gel ease menopause symptoms that disrupt daily life?
Knowledge-focused Not yet recruitingThis study examines the most common symptoms of genitourinary syndrome of menopause (GSM) in postmenopausal women and how these symptoms impact quality of life. Researchers will also look at whether using a non-hormonal topical gel called XCM INTIM for at least 8 weeks is linked …
Sponsor: Mucosa Innovations, S.L. • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
A simple look inside the uterus may reveal hidden inflammation — no lab needed
Knowledge-focused Not yet recruitingThis study asks whether visual signs seen during a hysteroscopy — a camera exam of the uterus — can reliably detect chronic endometritis, a long-term inflammation of the uterine lining. About 100 women already scheduled for hysteroscopy as part of their fertility care will take p…
Sponsor: Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita) • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Antioxidant-rich diets may fight inflammation in type 2 diabetes — a study investigates
Knowledge-focused Not yet recruitingThis observational study looks at whether the total antioxidant capacity of a person's diet is linked to levels of inflammation and nutritional health in adults with type 2 diabetes. Researchers will compare people with well-controlled blood sugar to those with poorly controlled …
Sponsor: Istanbul Bilgi University • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Gum inflammation in pregnancy linked to preterm birth risk?
Knowledge-focused Not yet recruitingThis study looks at whether inflammation from gum disease during pregnancy can affect the womb environment and lead to early delivery. Researchers will measure markers of inflammation and oxidative stress in saliva and amniotic fluid from 80 healthy pregnant women. The goal is to…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Can better surveillance of hepatitis b and d prevent liver damage?
Knowledge-focused Not yet recruitingThis observational study follows adults in France who are newly diagnosed with chronic hepatitis B (with or without hepatitis D). Researchers will measure liver scarring, treatment eligibility, and viral characteristics to understand how severe the disease is at diagnosis. The go…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Spotting hidden blood clots in scarred lungs: a study hunts for clues
Knowledge-focused Not yet recruitingPeople with interstitial lung disease (ILD) can suddenly get much worse, but it is hard to tell if the cause is a lung flare-up or a blood clot in the lungs (pulmonary embolism). This observational study will follow 70 adults with ILD who come to the hospital with worsening breat…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Mind over elbow: can beliefs predict how tennis elbow patients respond to treatment?
Knowledge-focused Not yet recruitingThis study investigates what factors — such as pain intensity, fear of movement, and confidence in managing pain — influence how adults with chronic tennis elbow perceive their illness and what they expect from treatment. Researchers will survey 137 participants and analyze the d…
Sponsor: Acibadem University • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
Knowledge-focused Not yet recruitingThis study is testing whether an integrated precision medicine platform can improve how doctors diagnose and manage chronic inflammatory lung diseases like COPD and idiopathic pulmonary fibrosis. Researchers will collect blood and saliva samples for biomarker analysis, monitor in…
Phase: NA • Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
What makes someone stop a lung fibrosis drug? a study asks patients directly
Knowledge-focused Not yet recruitingThis study uses web-based interviews to explore how adults in Japan with pulmonary fibrosis decide whether to continue or stop antifibrotic therapy after experiencing side effects. Researchers aim to understand the personal and psychological factors behind these decisions. The fi…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can frequent CRP checks prevent relapses in giant cell arteritis?
Knowledge-focused Not yet recruitingThis pilot study is investigating how quickly C-reactive protein (CRP), a key marker of inflammation, drops after starting steroid treatment in people newly diagnosed with giant cell arteritis. By measuring CRP levels daily, then weekly and monthly for up to a year, researchers h…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
A simple blood marker may reveal hidden heart risks in lupus
Knowledge-focused Not yet recruitingThis study investigates whether the triglyceride-glucose (TyG) index, a simple blood-based measure of insulin resistance, can predict early signs of atherosclerosis in people with lupus nephritis. Researchers will measure carotid artery thickness and plaque in 156 adults with lup…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Amniotic cell secretions may fight gut inflammation and scarring — a lab study puts them to the test
Knowledge-focused Not yet recruitingThis lab study tests whether a cell-free mixture of molecules and particles released by human amniotic mesenchymal stromal cells can reduce inflammation, prevent scarring, and promote healing in gut tissue from people with inflammatory bowel disease (Crohn's disease or ulcerative…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Ultrasound and blood markers may unlock personalized treatment for rare nerve disease
Knowledge-focused Not yet recruitingThis study investigates whether nerve ultrasound patterns and biomarkers in blood and spinal fluid can predict how people with chronic inflammatory demyelinating polyneuropathy (CIDP) respond to treatment. Researchers will follow 30 adults with CIDP, including newly diagnosed and…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can better detection of precancerous lesions in IBD prevent colorectal cancer?
Knowledge-focused Not yet recruitingPeople with inflammatory bowel disease (Crohn's disease or ulcerative colitis) have a higher risk of developing colorectal cancer. This study follows 800 adults with IBD who need a screening colonoscopy to look for precancerous growths called dysplasia. Researchers aim to underst…
Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Stomach lining may hold clues to pancreatitis outcomes
Knowledge-focused Not yet recruitingThis study looks at whether early endoscopic findings in the stomach and duodenum can help predict how severe acute pancreatitis will become. Researchers will perform an upper GI endoscopy within 24-48 hours of hospital admission in 200 adult patients with acute pancreatitis. The…
Sponsor: Jan Kochanowski University • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Hamstring showdown: eccentric lifts vs sprinting for muscle gains
Knowledge-focused Not yet recruitingThis study compares two types of hamstring training—eccentric exercises like the Romanian deadlift and Nordic hamstring exercise versus sprint-specific drills—in healthy collegiate athletes. Over 10 weeks, researchers measure changes in muscle size, strength, power, and sprint pe…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Listening to the unheard: how patients navigate cancer of unknown primary
Knowledge-focused Not yet recruitingThis study explores the personal stories of people diagnosed with cancer of unknown primary (CUP) and their carers. Through interviews and focus groups, researchers aim to understand the emotional and practical challenges of living with this uncertain diagnosis. The findings will…
Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Does the setting of care affect whether kids finish their antibiotics?
Knowledge-focused Not yet recruitingThis observational study looks at whether children aged 3 months to 16 years are more likely to complete their full course of antibiotics when prescribed at a primary care clinic versus a hospital emergency department. Researchers surveyed parents by phone after treatment ended t…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Allergy study seeks to pinpoint those most bothered by cats and birch pollen
Knowledge-focused Not yet recruitingThis study aims to identify and describe people with allergic conjunctivitis (eye allergies) caused by cats or birch tree pollen, with or without accompanying allergic rhinitis (hay fever). Researchers will collect information and perform allergy tests to see who qualifies for fu…
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Diabetes drugs may shield against severe pneumonia outcomes
Knowledge-focused Not yet recruitingThis study looks at whether taking a combination of GLP-1 receptor agonists and SGLT2 inhibitors before being hospitalized with pneumonia improves early outcomes in adults with type 2 diabetes. Researchers analyzed health records from over 70,000 patients, comparing those on both…
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
AI tutor takes on lupus nephritis: could chatbots teach doctors better?
Knowledge-focused Not yet recruitingThis trial tests an AI-powered teaching platform called iLN, which uses a large language model to help medical students learn about lupus nephritis. Fifty fourth-year medical students are randomly assigned to either use iLN or attend a traditional PowerPoint lecture. The study me…
Phase: NA • Sponsor: Nanjing University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Skin disease evolution under the microscope: a 17-Year look at what drives severity
Knowledge-focused Not yet recruitingThis study follows 5,000 people with common inflammatory skin conditions—like eczema, psoriasis, and hidradenitis suppurativa—over up to 17 years to see how their disease severity changes. Researchers will collect medical history, treatments, and symptom scores to identify factor…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Genetic clues may forecast multiple sclerosis after vision loss
Knowledge-focused Not yet recruitingThis observational study looks at whether combining genetic information with standard clinical data can better predict who will develop multiple sclerosis after a first episode of optic neuritis (inflammation of the optic nerve). Researchers will follow 180 people aged 16 and old…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Tiny study asks: can spine specialists see the same thing on CT?
Knowledge-focused Not yet recruitingThis study checks how consistently six doctors can grade degeneration of the small joints in the spine (facet joints) using CT scans. It includes 12 patients and uses the Pathria scale. The goal is to see if the grading method is reliable, not to test a treatment.
Sponsor: Sklifosovsky Institute of Emergency Care • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Blood fats and nanoparticles may reveal hidden clues in autoimmune liver disease
Knowledge-focused Not yet recruitingThis study looks at two types of liver disease — autoimmune hepatitis and non-alcoholic fatty liver disease — to see if fats in blood cells and tiny particles called extracellular vesicles differ between them. Researchers will collect blood samples from 24 adults and analyze thes…
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Eye surface disease study seeks to unlock vision predictors
Knowledge-focused Not yet recruitingThis study aims to find which eye tests best predict vision in people with surface eye diseases like neurotrophic keratopathy and limbal stem cell deficiency. Researchers will collect data from standard exams and patient questionnaires from 1,000 adults. The goal is to identify k…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Immune cell tracking could sharpen lyme disease diagnosis
Knowledge-focused Not yet recruitingThis study explores a new way to diagnose Lyme disease by measuring immune cell responses to the bacteria. Researchers use a technique called flow cytometry to analyze T-cells from patients with a late-stage form of Lyme disease. The goal is to see if this method can tell active …
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Blood cancer patients may need higher antibiotic doses to beat superbugs
Knowledge-focused Not yet recruitingThis study looks at whether the standard dose of the antibiotic ceftazidime-avibactam reaches high enough levels in the blood of people with blood cancers or those who have had a stem cell transplant. These patients are at high risk for severe infections from drug-resistant bacte…
Sponsor: Sizhou Feng • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Can a quick ultrasound help doctors decide faster on antibiotics for pneumonia?
Knowledge-focused Not yet recruitingThis pilot study tests whether using pleuropulmonary ultrasound in the emergency department can help doctors prescribe antibiotics sooner for suspected pneumonia. Fifteen adults with respiratory symptoms will receive an ultrasound in addition to standard care. The main goal is to…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Could a common tooth enamel defect trigger hidden gum inflammation?
Knowledge-focused Not yet recruitingThis study looks at whether children with molar-incisor hypomineralization (MIH) — a condition that weakens tooth enamel — have different levels of gum inflammation markers compared to children without MIH. Researchers will measure inflammatory substances in gum fluid from 76 chi…
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
CT scans track hip implant movement to predict Long-Term stability
Knowledge-focused Not yet recruitingThis study tracks 30 people receiving a CATALYSTEM cementless hip implant to measure how much the stem moves (subsides) in the thigh bone over two years. Using specialized CT scans, researchers aim to see if the implant stays firmly in place, which is key for long-term success. P…
Phase: NA • Sponsor: Canadian Radiostereometric Analysis Network • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Tiny bacterial particles linked to lung damage in sepsis patients
Knowledge-focused Not yet recruitingThis study investigates whether a particularly dangerous strain of Klebsiella pneumoniae bacteria (hvKP) raises the risk of lung injury in adults with sepsis, compared to a more common strain. Researchers will analyze blood samples for tiny bacterial particles and markers of a sp…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New oral drug for eczema takes first step in human safety trial
Knowledge-focused Not yet recruitingThis early-stage study tests the safety and tolerability of an experimental oral drug called HRS-8797 in healthy volunteers aged 18 to 55. Researchers will also measure how the drug behaves in the body and whether food affects its absorption. The goal is to gather essential safet…
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Blood test may spare ER patients from unneeded scans for clots
Knowledge-focused Not yet recruitingSuperficial vein thrombosis (SVT) is a painful but usually harmless blood clot just under the skin. However, about 4% of people develop more serious clots in deep veins or lungs. Current guidelines recommend ultrasound scans to decide if blood thinners are needed, but scans are o…
Sponsor: Dr. Kerstin de Wit • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Fermented chickpeas may tame inflammation through gut bacteria
Knowledge-focused Not yet recruitingThis trial tests whether eating fermented chickpeas can reduce inflammation by changing the gut microbiome. Healthy adults will eat prepared meals with either fermented or unfermented chickpeas, and researchers will compare markers of inflammation and gut bacteria. The goal is to…
Phase: NA • Sponsor: Penn State University • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Chewing gum test reveals hidden impact of gum disease
Knowledge-focused Not yet recruitingThis study will measure how well people with gum disease can chew. One hundred adults with periodontitis will chew a special gum for 20 cycles to test their chewing performance. Researchers will also check the severity of their gum disease to see if there is a link. This is an ob…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Gum treatment may improve chewing, study hopes to prove
Knowledge-focused Not yet recruitingThis study looks at whether treating gum disease (periodontitis) can improve how well people chew and their overall oral quality of life. Researchers will ask 44 adults with gum disease to fill out questionnaires, do a chewing test with colored gum, and provide saliva samples. Th…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Dutch hospital data reveals hidden patterns in IBD treatment
Knowledge-focused Not yet recruitingThis study looks at medical records from thousands of adults with Crohn's disease or ulcerative colitis treated in Dutch hospitals between 2018 and 2026. Researchers will analyze which treatments patients receive, how often they switch therapies, and how the disease affects other…
Sponsor: LOGEX • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Gut microbes may hold key to diverticular disease
Knowledge-focused Not yet recruitingThis study investigates whether the bacteria living in the gut influence the development of diverticular disease and acute diverticulitis. Researchers will compare the gut microbiota of people with and without these conditions to identify differences and risk factors. The goal is…
Sponsor: Hospital of Navarra • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Acupuncture points may signal hidden disease activity
Knowledge-focused Not yet recruitingThis study investigates whether acupuncture points become tender or more sensitive in people with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. Researchers will compare skin temperature, blood flow, and pain sensitivity at specific body points b…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New drug candidate SCB0020160 enters first human safety tests
Knowledge-focused Not yet recruitingThis phase 1 trial tests a new investigational drug, SCB0020160, for the first time in humans. Healthy adult men aged 18 to 65 receive either the drug or a placebo to evaluate safety, tolerability, and how the drug moves through the body. The study also looks at whether food affe…
Phase: PHASE1 • Sponsor: SCBIO Inc. • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Pneumonia culprit may be rarer than doctors think
Knowledge-focused Not yet recruitingThis study looks at 200 people with pneumonia to find out how many actually have an infection caused by Chlamydia pneumoniae, a type of bacteria. Researchers will use PCR tests to check for the germ and compare results with standard care. The goal is to see if this infection is o…
Sponsor: Centre Hospitalier de Saint-Denis • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Spine fracture study to reveal hidden degeneration risks
Knowledge-focused Not yet recruitingThis observational study will follow 150 people with thoracolumbar spine fractures to see how the injury and its treatment (surgery or non-surgical care) affect joint and disc degeneration over time. Researchers will compare CT scans and pain scores between treated patients and a…
Sponsor: Sklifosovsky Institute of Emergency Care • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Timing of gum disease check-ups could change treatment success
Knowledge-focused Not yet recruitingThis study looks at whether checking gum health 4 weeks after non-surgical treatment is better than waiting 8-10 weeks. Researchers will compare healing and pocket depth in 24 adults with advanced gum disease. The goal is to find the best time for follow-up to improve care.
Phase: NA • Sponsor: Gulf Medical University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New study uses DNA to track hidden gonorrhea in partners
Knowledge-focused Not yet recruitingThis study will recruit 100 sexual partners of people diagnosed with gonorrhea. Researchers will take an extra throat swab to analyze all the bacteria and their genes using a technique called metagenomics. The goal is to find hidden infections, antibiotic resistance, and see how …
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple heart catheter test predict serious complications after myocarditis?
Knowledge-focused Not yet recruitingThis study investigates whether measuring blood flow in the heart's smallest blood vessels (microcirculation) can help predict serious health events within a year after a person is hospitalized for acute myocarditis. Researchers will use a special technique during a standard hear…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Will a new drug form work the same? study tests two versions of SKI-O-703
Knowledge-focused Not yet recruitingThis study tests whether two different capsule forms of the experimental drug SKI-O-703 are absorbed similarly in the body. About 48 healthy adults (Korean and Caucasian) will take a single dose of each form on separate days, with blood samples taken to compare drug levels. The r…
Phase: PHASE1 • Sponsor: Oscotec Inc. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Home devices may spot lung flare-ups before they become emergencies
Knowledge-focused Not yet recruitingThis study tests whether people with fibrotic interstitial lung disease can use home monitoring devices—like a spirometer, pulse oximeter, and scale—to help detect serious lung events such as flare-ups or hospitalizations. About 200 participants will use these devices connected t…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Smartwatches may spot IBD flares before symptoms start
Knowledge-focused Not yet recruitingThis study explores whether changes in heart rate, sleep, and activity measured by a person's own smartwatch can predict flare-ups in inflammatory bowel disease (IBD). Six hundred adults with Crohn's disease or ulcerative colitis who already own a compatible device will participa…
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists launch study to decode why diabetes affects people differently
Knowledge-focused Not yet recruitingThe EXPAND study is a research project that will enroll 440 adults with and without pancreatic conditions to understand why type 2 diabetes varies so much from person to person. Researchers will collect data on metabolism, genetics, and pancreas health to identify distinct diabet…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Knee pain relief starts in the mind: new study tests a health aid to bust common myths about osteoarthritis.
Knowledge-focused Not yet recruitingThis study will test whether a short health aid—a tool that corrects common misunderstandings about knee osteoarthritis—can help patients feel less worried and make clearer treatment choices. About 159 adults with knee osteoarthritis will be randomly assigned to review the health…
Phase: NA • Sponsor: David Ring • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can AI predict heart trouble in IBD patients?
Knowledge-focused Not yet recruitingThis study looks at people with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, to better understand their risk of serious heart problems like stroke and heart attack. Researchers will collect information on therapy, disease activity, lifestyle…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Rare bone infection study aims to uncover best treatment paths
Knowledge-focused Not yet recruitingThis study follows 100 adults diagnosed with skull base osteomyelitis, a rare and serious bone infection near the ear and skull base. Researchers will track how often the infection returns or leads to death within 12 months. The goal is to gather real-world data to help standardi…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists watch thumb muscles in action to improve osteoarthritis rehab
Knowledge-focused Not yet recruitingThis study looks at how two thumb muscles work in people with and without thumb base osteoarthritis while they do six daily tasks like turning a key or writing. Researchers will use sticky sensors to record muscle activity. The goal is to find differences that could lead to bette…
Sponsor: University of Malaga • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Brain scans reveal why some knee pain feels different
Knowledge-focused Not yet recruitingThis study uses brain MRI to compare brain activity in women over 40 with knee osteoarthritis who have two different types of pain: joint-related pain and nerve-related pain. Researchers will look at a brain region called the anterior insula to see if activity differs between the…
Phase: PHASE2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could skipping bowel prep before colon surgery be just as safe?
Knowledge-focused Not yet recruitingThis study looks at whether it's safe to skip mechanical bowel preparation (the drink that cleans out your colon) before colon surgery. Currently, the best practice combines that drink with antibiotics to prevent infections. The trial will compare two groups: one getting the drin…
Phase: NA • Sponsor: Mount Sinai Hospital, Canada • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New blood test may predict infection risk after liver transplant
Knowledge-focused Not yet recruitingThis study aims to create a score that predicts the risk of infection within 30 days after a liver transplant. Researchers will collect blood samples from 279 liver transplant patients before and after surgery to measure immune markers. The goal is to combine these markers with o…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could we ditch antibiotics after a burst appendix? new study investigates
Knowledge-focused Not yet recruitingThis pilot study looks at whether it is safe to stop giving antibiotics after surgery for a burst (perforated) appendix. About 100 adults will be randomly assigned to receive either antibiotics or no antibiotics after their operation. The main goal is to see if a larger study is …
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Emotional blindness may sabotage knee pain therapy
Knowledge-focused Not yet recruitingThis study investigates whether alexithymia—a condition where people struggle to identify and describe their emotions—affects how well patients with knee osteoarthritis respond to physical therapy. Sixty participants aged 40 to 75 with moderate knee osteoarthritis will receive a …
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC